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Abstract 
The current demographical development leads to a growing number of older people 
and thereby to an increase in patients suffering from age-related diseases like 
dementia. Facing this healthcare challenge requires an efficient and accurate 
diagnostic process. An understanding of healthy cognitive aging is essential to 
recognize and investigate pathological states. Further the diagnostic accuracy of a 
given tool needs to be assessed in the clinical setting where it is ultimately applied. 
The aim of the present doctoral thesis is to provide insights into the cognitive 
performance of cognitively healthy older individuals and to assess the diagnostic 
accuracy of a well-known tool in a realistic clinical routine setting. 
We found demographic-related effects on cognitive performance in 283 cognitively 
healthy individuals who were assessed with two different cognitive assessment 
tools: the Montreal Cognitive Assessment (MoCA) and a newly developed 
computerized cognitive assessment (CogCheck). Adjusting for these effects by 
converting raw scores to standard scores, lead to higher specificity of the MoCA. 
In a second study, we investigated the diagnostic accuracy of the original MoCA 
cut-off (25/26) in a clinical routine setting to differentiate cognitive normal findings 
from patients with a neurocognitive disorder (NCD; N = 496). While the original cut-
off yielded high sensitivity, its specificity was poor. The classification rate increased 
when a lower cut-off score (23/24) was applied. However, sensitivity to detect mild 
NCD was low. We therefore proposed a new way to evaluate cognitive 
performance: Combining two separate cut-offs (23/24 and 26/27) with a gray area 
allows for both, high specificity and high sensitivity. Additional examinations are 
required in the gray area between these two cut-offs. 
Finally, we have found important heterogeneities in the methodology of cognitive 
normative studies. This information may guide future endeavors to create 
guidelines for the definition of cognitive health, which is a baseline requirement to 
investigate pathological changes. As an outlook, methodological reflections on the 
evaluation of cognitive assessments are given and the role of neuropsychology in 
the age of digitalization is discussed.  
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1. General introduction 
The current demographical development is characterized by a growing number of 
older individuals and thereby an increase in patients suffering from age-related 
diseases. For instance, dementia cases are estimated to nearly triple and reach 
131.5 million patients by the year 2050 (Prince, Comas-Herrera, Knapp, Guerchet, 
& Karagiannidou, 2016). Dementia as a clinical syndrome is characterized by 
cognitive impairment that interferes with activities of daily living and represents a 
decline from a previous level of functioning. It may be caused by a variety of 
underlying etiologies with Alzheimer’s disease (AD) being the leading one (Winblad 
et al., 2016). While some forms of dementia and cognitive impairment are 
potentially reversible if treated appropriately (Clarfield, 2003), there are currently 
no satisfying care options for neurodegenerative diseases like AD. Incipient 
pharmaceutical or non-pharmaceutical therapies target early stages of the disease 
(Scheltens et al., 2016), making early-detection of cognitive impairment crucial. 
Moreover, an early implementation of current treatment strategies may slow 
progression of cognitive decline, allows the treatment of secondary behavioral or 
psychiatric symptoms and the organization of care support; thereby increasing the 
patients’ and their caregivers’ quality of life (Petersen et al., 2017). However, 
diagnosing AD (and other neurodegenerative diseases) is still challenging and i t is 
especially difficult in earlier disease stages when only subtle symptoms are 
apparent. 
The growth of the geriatric patient population furthermore has an impact on the 
hospital setting. The need for surgical procedures increases with age (Hall, 
DeFrances, Williams, Golosinskiy, & Schwartzman, 2010) and older people have a 
higher risk for adverse postoperative cognitive outcomes like postoperative delirium 
(POD) or postoperative cognitive dysfunction (POCD) (Story et al., 2010). These 
cognitive disorders are in turn associated with higher morbidity and mortality 
(Sanders, Pandharipande, Davidson, Ma, & Maze, 2011; Steinmetz, Christensen, 
Lund, Lohse, & Rasmussen, 2009; Witlox et al., 2010). Individuals with a higher 
risk for POD or POCD may benefit from preventive measures or increased 
postoperative care (Inouye et al., 1999), making preoperative identification of risk 
factors essential.  
Consequently, the increasing number of geriatric patients is associated with 
important health-related, economic, and social challenges. Addressing these 
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confronts is a priority in healthcare. The field of neuropsychology, which 
investigates brain-behavior relationships, offers important contributions to this aim. 
Cognitive dysfunction is the primary deficit in dementia (American Psychiatric 
Association, 2013) and cognitive assessment plays an essential role for differential 
diagnosis, for the assessment of disease severity, for predictions on the disease 
course, and as a measure of treatment success. In the context of adverse 
postoperative outcomes, pre-existing cognitive impairment is one of the leading risk 
factors (Dasgupta & Dumbrell, 2006; Inouye, Westendorp, & Saczynski, 2014; 
Jones et al., 2016; Nadelson, Sanders, & Avidan, 2014; Silbert et al., 2015; Sprung 
et al., 2017). Preoperative cognitive assessment may therefore help identifying 
high-risk surgery patients who could benefit from increased pre- and post-operative 
care. 
 
1.1 Cognitive assessment: contributions and challenges 
In the 5th version of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5; American Psychiatric Association, 2013), disorders with acquired 
cognitive impairment as the leading clinical symptom are referred to as 
neurocognitive disorder (NCD). NCDs are further divided in two levels of severity, 
with the previously introduced term dementia being referred to as major NCD. Major 
NCD is characterized by a decline of more than two standard deviations (SD) from 
a healthy normative population in at least one cognitive domain. Further, the 
cognitive deficits interfere with independent functioning in everyday life. A minor 
form of NCD is entitled mild NCD and relates to the concept of Mild cognitive 
impairment (MCI; Petersen, 2004). Patients with mild NCD typically score in the 
range of one to two standard deviations (SD) from a healthy normative population 
in at least one cognitive domain and are still independent in everyday activities. Of 
note, there is no clear border between these two entities since cognitive decline 
represents a continuum rather than distinct categories. NCD may be caused by a 
variety of underlying diseases (i.e., AD, frontotemporal lobar degeneration, Lewy 
body disease, vascular disease, traumatic brain injury, substance/medication use, 
human immunodeficiency virus infection, prion disease, Parkinson’s disease, 
Huntington’s disease, other medical conditions, or multiple etiologies). The 
diagnostic criteria for mild and major NCD are based on the following six cognitive 
domains that should be evaluated in a comprehensive neuropsychological 
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assessment: Perceptual-motor function, executive function, complex attention, 
language, social cognition, learning and memory. A comprehensive assessment 
should include at least two different measures per domain. 
Many currently used cognitive assessment tools have been developed decades 
ago (e.g., Mini-Mental State Examination in 1975 [Folstein, Folstein, & McHugh, 
1975], Consortium to Establish a Registry for Alzheimer’s Disease –
Neuropsychological Assessment Battery in 1989 [Morris et al., 1989], Stroop-Test 
in 1935 [Stroop, 1935]). Therefore, new evidence on brain-behavior-relationships 
is often not considered in standard cognitive assessments. This may partly be due 
to the lack of available normative data for more recent cognitive assessment tools. 
The evaluation of cognition requires a definition of what is normal and a concept of 
deviations that constitute an impairment. Additionally, the performance in cognitive 
tests may be influenced by demographic characteristics like age, education, and 
sex (Casaletto & Heaton, 2017). Further, culture and language may have an impact 
on item-difficulty. Therefore, it is important to investigate the performance of healthy 
individuals that are comparable to the target population, before applying a cognitive 
test in a clinical setting. Conducting large-scale normative studies for every new 
test and for many specific populations would be ideal. However, this type of studies 
is expensive and is usually not financially supported (Casaletto & Heaton, 2017). 
Consequently, representable norms for the patient population are often lacking 
and/or the available norms have been developed based on previous generations of 
individuals, which may be outdated. 
Like every diagnostic test, cognitive assessment tools should have sufficient 
validity and high diagnostic accuracy. False-negative diagnoses due to a lack of 
sensitivity deprives patients from access to treatment or clinical trials. On the other 
hand, false-positive diagnoses due to poor specificity leads to avoidable stress and 
burden for a patient, costs due to unnecessary examinations and treatments, and 
inappropriate inclusion in clinical trials. Since in the context of neurodegenerative 
diseases there is no clear benefit of favoring false-positives over false-negatives or 
vice-versa, sensitivity and specificity should be balanced. 
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1.2 Diagnostic steps for cognitive impairment and dementia 
In the diagnostic workup for dementia, patients are usually first seen by a general 
practitioner (GP). At this level, a case-finding approach rather than broad screening 
has been recommended (Ehrensperger et al., 2014), meaning that brief cognitive 
assessment tools should only be applied in those individuals that present with red 
flags indicative of possible cognitive impairment (e.g., report of cognitive worsening 
by the patient or an informant; signs of cognitive worsening that become apparent 
to the clinician during routine examination). A pathological result in a first-step test 
is usually followed by a referral to a specialized clinic where extensive 
neuropsychological and medical examinations take place. A comprehensive 
dementia workup should include detailed patient and medical history—if possible 
combined with reports from an informant—, a comprehensive neuropsychological 
assessment, a neurological and geriatric evaluation, laboratory diagnostics, brain 
imaging (magnetic resonance imaging [MRI]; positron emission tomography [PET]), 
and sometimes the assessment of protein depositions in cerebrospinal fluid or PET 
(Frisoni et al., 2017).  
In conclusion, the diagnostic process of dementia is a multi-disciplinary workup, it 
includes identification processes at different levels (i.e. the GP level and the 
specialist level), it is time-consuming, expensive, personnel-intensive, and 
sometimes invasive (e.g. lumbar puncture to collect CSF). Additionally, the number 
of patients with dementia are rapidly increasing and specialized clinics are already 
facing long waiting lists. Thus, it is crucial to apply tools with high diagnostic 
accuracy to detect those patients that should benefit from such extensive 
assessments while at the same time filter out healthy individuals that should not 
undergo unnecessary examinations. Ideally, such first-step tools should be brief  
and inexpensive, and their administration should not require highly trained 
personnel. This becomes even more important, if there should one day be a 
treatment for AD with a significant positive effect. It is reasonable to imagine, that 
in this scenario, waiting lists would drastically increase. 
Therefore, one main challenge of the field is finding ways to improve the efficiency 
of the diagnostic process while still providing high diagnostic accuracy. This may 
be achieved by targeting (a) current screening procedures at the GPs office, and 
(b) examinations at the specialized level. A more efficient assessment of pre-
  
  13 
existing cognitive impairment may also be beneficial in the pre-surgery setting 
where time is limited and trained neuropsychologists are usually absent. 
1.2.1 First level: General practitioners’ office 
On the GP level, many screening tools exist to briefly assess for cognitive 
impairment. In this context, the Mini-Mental state examination (MMSE) is probably 
the most-known test and it has been used during decades for cognitive screening. 
However, like many other cognitive tools, the MMSE has been developed in the 
70ies and only poorly assesses the six cognitive domains proposed in the DSM-5 
(2013). There is growing evidence, that the MMSE has poor sensitivity, especially 
to detect subtle cognitive deficits that are present in MCI (Ciesielska et al., 2016; 
Nasreddine et al., 2005; Roalf et al., 2013). To address this issue, other screening 
tools have been developed, some of them with a special focus on the detection of 
MCI like the Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005). 
Compared to the MMSE, the MoCA has superior diagnostic accuracy for MCI 
(Ozer, Young, Champ, & Burke, 2016; Trzepacz et al., 2015), correlates better with 
extensive neuropsychological test batteries (Lam et al., 2013), and covers most of 
the cognitive domains outlined in the DSM-5 (2013). Namely, executive functions 
and complex attention are assessed, which are not considered in the MMSE. While 
the MoCA gains popularity as an alternative to the MMSE, there are still some 
concerns that need to be addressed. The initially proposed MoCA cut-off score 
(25/26 points) has poor specificity (Carson, Leach, & Murphy, 2018; Davis et al., 
2015) and demographical characteristics are not appropriately considered. So far, 
no study has investigated the properties of the German MoCA in cognitively healthy 
individuals and patients, why most German-speaking clinicians still rely on this cut-
off. With false-positive rates ranging from 46% (Malek-Ahmadi et al., 2015) up to 
76% (Rossetti et al., 2017) in other MoCA normative studies, the use of this cut-off 
may seriously decrease the efficiency of the case-finding process and may lead to 
many false-positive referrals to specialized clinics. Therefore, in study I and II we 
aimed at investigating the properties of the German MoCA and deducting ways to 
decrease the false-positive rate while at the same time keeping sensitivity for 
cognitive impairment high. In study I, we assessed the MoCA performance in 
cognitively healthy individuals and investigated whether age, education, and/or sex 
have an impact on MoCA scores. In study II, we completed this knowledge with 
patient data and analyzed ways to increase the diagnostic accuracy of the MoCA 
to distinguish healthy individuals form patients with mild or major NCD. 
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 1.2.2 Second level:  Comprehensive cognitive assessment 
In earlier years of neuropsychological assessment, cognitive functions were usually 
evaluated in a qualitative way, which tailors the examination to the needs and 
characteristics of a specific patient (Casaletto & Heaton, 2017). Over the years, 
quantitative assessments have gained popularity to increase comparability and 
reproducible results. Today, fixed batteries that include tests on the most important 
cognitive domains are often performed as a standard in all patients. A standard 
assessment may then be combined with more specific tests and in-depth 
assessments if needed. Generally, a comprehensive neuropsychological 
assessment is time-consuming and takes up to two hours for the test administration 
plus additional time for test scoring and interpretation. Additionally, trained 
personnel is required to perform and interpret the assessments. 
Considering the availability of modern technologies, computerized cognitive 
assessment tools gain increasing attention and are a potential way to increase the 
efficiency of this process. Especially in a setting, where many individuals should be 
assessed for cognitive impairment, a computerized cognitive assessment that may 
be performed without the assistance of a trained professional yields interesting 
possibilities and may reduce costs. 
However, before a computerized assessment tool can be applied in a clinical 
setting, it should undergo the same development and validation steps as traditional 
paper-and-pencil-tests. It needs to be assessed for feasibility in the target 
population, normative data should be developed, and its diagnostic accuracy must 
be investigated. In a joint-collaboration between the Department of Anesthesia of 
the University Hospital Basel and the Memory Clinic, University Department of 
Geriatric Medicine FELIX PLATTER, Basel, a new self-administered computerized 
cognitive assessment tool (CogCheck) has been developed and tested for 
feasibility in two pilot-studies (Anyiam, 2018; Burckhardt, 2014). In study III, 
CogCheck was administered to cognitively healthy individuals to assess the ef fect 
of age, education, and sex on the CogCheck performance and to provide normative 
values for the tool. 
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ABSTRACT 
Background: The Montreal Cognitive Assessment (MoCA) is used to evaluate 
multiple cognitive domains in elderly individuals. However, it is influenced by 
demographic characteristics that have yet to be adequately considered. 
Objective: The aim of our study was to investigate the effects of age, education, 
and sex on the MoCA total score and to provide demographically adjusted 
normative values for a German-speaking population. 
Methods: Subjects were recruited from a registry of healthy volunteers. Cognitive 
health was defined using the Mini-Mental State (score ≥ 27/30 points) and the 
Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological 
Assessment Battery (total score ≥ 85.9 points). Participants were assessed with 
the German version of the MoCA. Normative values were developed based on 
regression analysis. Covariates were chosen using the Predicted Residual Sums 
of Squares approach. 
Results: The final sample consisted of 283 participants (155 women, 128 men; 
mean (SD) age = 73.8 (5.2) years; education = 13.6 (2.9) years). Thirty-one percent 
of participants scored below the original cut-off (< 26/30 points). The MoCA total 
score was best predicted by a regression model with age, education, and sex as 
covariates. Older age, lower education, and male sex were associated with a lower 
MoCA total score (p < 0.001). 
Conclusion: We developed a formula to provide demographically adjusted 
standard scores for the MoCA in a German-speaking population. A comparison with 
other MoCA normative studies revealed considerable differences with respect to 
selection of volunteers and methods used to establish normative data. 
 
Keywords: Elderly individuals, healthy participants, mild cognitive impairment, 
Montreal Cognitive Assessment, regression analysis   
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3.1 INTRODUCTION 
Due to the demographical development, age-related diseases will drastically 
increase over the next decades. Today, 46.7 million people are suffering from 
dementia worldwide – a number that is estimated to nearly triple by 2050 and reach 
131.5 million cases (Prince et al., 2016). To face this healthcare challenge, early 
and accurate identification of cognitive impairment is crucial. Mild cognitive 
impairment (MCI) may represent a stage along the clinical continuum of 
Alzheimer’s disease, and currently there are no drugs proven effective for this 
disease stage (Petersen et al., 2017). However, implementing off-label 
pharmacological treatment might be beneficial in certain patients; non-
pharmacological interventions should be initiated; behavioral or psychiatric 
symptoms common in MCI may be treated; and there is time to consider important 
life choices when a patient is still able to do so (Petersen et al., 2017). Additionally, 
future pharmacological interventions against Alzheimer’s disease (AD) ma inly 
target patients in an incipient disease stage (Scheltens et al., 2016), and about 10% 
of the causes of cognitive impairment are reversible (Clarfield, 2003). 
The early detection of cognitive decline requires a tool that is short, easy to 
administer and interpret, and has high diagnostic accuracy. Currently, a widely-
used instrument is the Mini-Mental State Examination (MMSE; Folstein et al., 
1975). However, the MMSE sensitivity is poor when identifying individuals with MCI 
(Ciesielska et al., 2016; Nasreddine et al., 2005; Roalf et al., 2013), and it lacks 
meaningful assessment of executive functions (Fu et al., 2017). The Montreal 
Cognitive Assessment (MoCA; Nasreddine et al., 2005) has been developed to 
address these weaknesses. It has demonstrated better diagnostic accuracy in 
patients with MCI (Ozer et al., 2016; Trzepacz et al., 2015), has less ceiling effect 
(Trzepacz et al., 2015), and a higher test-retest-reliability (Ozer et al., 2016). In 
addition, the MoCA better captures the cognitive domains proposed in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American 
Psychiatric Association, 2013). Accordingly, previous research has demonstrated 
good practical utility of the MoCA as a diagnostic tool in various diseases affecting 
cognition (Borland et al., 2017). 
Yet, the implementation of the MoCA has some limitations. First, the proposed cut-
off score of 26 out of 30 points (Nasreddine et al., 2005) has been criticized for 
being too conservative. A recent review found that MoCA specificity was 60% or 
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lower when applying this cut-off score (Davis et al., 2015), thus, bearing a high risk 
of false-positive classifications. Second, possible demographic effects on cognitive 
performance are not well addressed in the original MoCA, which only includes a 
basic correction for education (+1 point for individuals with ≤ 12 years of education). 
However, it has been shown that age and – less consistently – sex may influence 
MoCA scores (Abou-Mrad et al., 2017; Borland et al., 2017; Conti, Bonazzi , 
Laiacona, Masina, & Coralli, 2015; Freitas, Simoes, Alves, & Santana, 2011; Kenny 
et al., 2013; Konstantopoulos, Vogazianos, & Doskas, 2016; Kopecek et al., 2017; 
Larouche et al., 2016; Lu et al., 2011; Malek-Ahmadi et al., 2015; Narazaki et al., 
2013; Nasreddine, Phillips, & Chertkow, 2012; Nasreddine et al., 2005; Pereiro et 
al., 2017; Rossetti, Lacritz, Cullum, & Weiner, 2011; Rossetti et al., 2017; 
Santangelo et al., 2015). Finally, the MoCA performance may vary across different 
cultures and languages (Rossetti et al., 2011). Accordingly, normative values for 
the MoCA have been established in several countries (Abou-Mrad et al., 2017; 
Borland et al., 2017; Conti et al., 2015; Freitas et al., 2011; Kenny et al., 2013; 
Konstantopoulos et al., 2016; Kopecek et al., 2017; Larouche et al., 2016; Lu et al., 
2011; Malek-Ahmadi et al., 2015; Narazaki et al., 2013; Nasreddine et al., 2012; 
Nasreddine et al., 2005; Pereiro et al., 2017; Rossetti et al., 2011; Rossetti et al., 
2017; Santangelo et al., 2015). The results show great variability; most importantly 
there are substantial differences regarding the empirically derived MoCA cut-off 
scores (Abou-Mrad et al., 2017; Borland et al., 2017; Conti et al., 2015; Freitas et 
al., 2011; Kenny et al., 2013; Konstantopoulos et al., 2016; Kopecek et al., 2017; 
Larouche et al., 2016; Lu et al., 2011; Malek-Ahmadi et al., 2015; Narazaki et al., 
2013; Nasreddine et al., 2012; Nasreddine et al., 2005; Pereiro et al., 2017; 
Rossetti et al., 2011; Rossetti et al., 2017; Santangelo et al., 2015). Consequently, 
a general cut-off for all populations might not be suitable, and diagnostic accuracy 
may be improved when a cut-off score is based on culture-specific and 
demographically adjusted normative values. 
To our knowledge, normative values for the German version of the MoCA have not 
yet been established. The aim of our study was to evaluate the effects of age, 
education, and sex on the MoCA and to create demographically adjusted norms for 
the German version. This report also provides a comparison of normative data from 
other international samples. 
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3.2 MATERIALS AND METHODS 
3.2.1 Participants 
Ethical approval for the study (N° EKNZ 2016-00393) was provided by the 
Ethikkommission Nordwest- und Zentralschweiz (EKNZ) on April 12, 2016. The 
study was performed in respect of the most recent version of the Declaration of 
Helsinki and was registered on ClinicalTrials.gov (NCT03246269). 
Participants were recruited from an existing Registry of Individuals Interested to 
Participate in Research established by the Memory Clinic, University Center for 
Medicine of Aging, Felix Platter Hospital in Basel, Switzerland. The detailed study 
flow chart is shown in Figure 1. The registry was established in 2013 with approval 
from the local ethics committee (N° EKBB 280/1). Individuals were informed about 
the registry and the possibility to sign-up by means of newspaper advertisements, 
television interviews, and public scientific lectures. Each time a study with normal 
control subjects was initiated at the Memory Clinic, potential participants with the 
required demographic characteristics (age, education, sex) were identified from the 
registry and invited to provide information about their medical history by completing 
a detailed medical questionnaire (see Supplementary Figure 1 for an English 
translation of the medical questionnaire). At the beginning of the current study in 
December 2016, the registry consisted of 2,162 individuals. Seven-hundred and 
ninety-four had previously provided their medical history and were considered 
during the recruitment process of this study. Four-hundred and eighty-seven 
individuals remained eligible for telephone screening after applying inclusion and 
exclusion criteria (see below). During the telephone screening, a further 
assessment of exclusion criteria was performed, and 153 subjects were excluded. 
Thus, 334 individuals were assessed between December 2016 and April 2017, and 
the data of 283 subjects were included in the final analysis (see study flow chart for 
details).  
During the recruitment process, a stratification of sex (female and male) and age 
(groups: 65–69, 70–74, 75–79, and > 79 years) was applied to obtain age groups 
with at least 20 women and 20 men each. The aim was to include only cognitively 
healthy individuals by applying the following criteria. Inclusion criteria were: (1) age 
≥ 65 years, (2) education ≥ 7 years, (3) fluent German-speaking, and (4) provided 
written informed consent. Subjects who met one of the following criteria were 
excluded: (1) cognitive impairment (i.e., MMSE < 27/30 and/or Consortium to 
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Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment 
Battery [CERAD-NAB] < 85.89; Ehrensperger, Berres, Taylor, & Monsch, 2010), 
any diagnosis of cognitive impairment), (2) diagnosis and/or symptoms of 
depression (i.e., Geriatric Depression Scale [GDS]; Yesavage & Sheikh, 1986) > 
5/15), (3) severe sensory or motor impairment interfering with cognitive testing, (4) 
serious somatic disease, (5) any disease or events affecting the central nervous 
system, (6) cerebrovascular disease, (7) current medication with psychoactive 
drugs except for benzodiazepines, and (8) participation in a cognitive study within 
the last 3 months (to avoid practice effects). 
 
Fig. 1. Study flow chart. 
1Based on neuropsychological test results in previous studies and/or individuals 
with any diagnosis of cognitive impairment. 
2Based on information provided in the medical questionnaire. 
3Signs of depression: reported symptoms of depression and/or current diagnosis 
of depression and/or current psychotherapy for depression. 
4Severe sensory or motor impairment: any visual or auditory impairment not 
correctable with (reading) glasses or hearing aids; motor impairment of the upper 
extremity (e.g., essential tremor, paresis, dyskinesia). 
5Serious somatic disease (i.e., current chemo- or radiotherapy; severe cardiac, 
pulmonary, renal, gastrointestinal, or endocrine disease interfering with everyday 
functioning). 
6Disease or event affecting the central nervous system (i.e., meningitis, 
encephalitis, severe traumatic brain injury with loss of consciousness > 5 minutes, 
intoxication with neurotoxic substances, prior intracranial neurosurgery, general 
anesthesia within the last three months, previous or current substance addiction 
[drugs, alcohol, medication]). 
7Cerebrovascular disease (i.e., stroke, transient ischemic attack). 
8Regular intake of psychoactive drugs (i.e., for treatment of schizophrenia, bipolar 
disorder, obsessive compulsive disorder, personality disorder; substance-induced 
mental disorder). 
9Macular degeneration (n = 1), hearing impairment interfering with cognitive 
testing (n = 1).  
10Suspected Parkinson’s disease (n = 1), general anesthesia within the last three 
months (n = 1). 
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Fig. 1 Study Flow chart. 
 
 
11Subject was verbally offensive towards test administrator (n = 1); subject 
deliberately made mistakes during cognitive testing (n = 1). 
 
CERAD-NAB = Consortium to Establish a Registry for Alzheimer's Disease-
Neuropsychological Assessment Battery; GDS-15 = Geriatric Depression Scale 
(15 items; no subject scored > 5/15 points); MMSE = Mini-Mental State 
Examination; MoCA = Montreal Cognitive Assessment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not eligible (n = 307) 
• Age < 65 years 
• Known cognitive impairment1 and/or meeting any other 
exclusion criteria2 
Registry of Individuals Interested to 
Participate in Research 
(n = 2,162) 
Medical questionnaire on file 
(n = 794) 
Drop-out (n = 51) 
• No fluency in the German language (n = 4) 
• Education < 7 years (n = 1) 
• Signs of cognitive impairment in MMSE (n = 7), CERAD-
NAB (n = 28), or both (n = 4) 
• Severe sensory or motor impairment9 (n = 2) 
• Disease or event affecting the central nervous system10  
(n = 2) 
• Withdrew consent (n = 1) 
• Inappropriate behavior11 (n = 2) 
Final sample used for analyses 
(n = 283) 
Excluded (n = 153) 
• Signs of depression3 (n = 4) 
• Severe sensory or motor impairment4 (n = 9) 
• Serious somatic disease5 (n = 10) 
• Disease or event affecting the central nervous system6   
(n = 28) 
• Cerebrovascular disease7 (n = 14) 
• Regular intake of psychoactive drugs8 (n = 4) 
• Participation in any cognitive study within the last 3 
months (n = 12) 
• Could not be contacted or deceased (n = 16) 
• Declined to participate (n = 56) 
Telephone screening 
(n = 487) 
Included and assessed 
(n = 334) 
Sequence of assessments: 
1. Written informed consent 
2. Demographic data 
3. Medical questionnaire update 
4. MMSE 
5. GDS-15 
6. MoCA 
7. CERAD-NAB 
Medical questionnaire not on file 
(n = 1,368) 
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3.2.2 Procedures 
After obtaining written informed consent, the medical history provided in the 
medical questionnaire was updated. Then, study eligibility was further assessed 
with the German versions of the MMSE (Folstein et al., 1975) and the 15-item GDS 
questionnaire (Yesavage & Sheikh, 1986). After completing these screening 
procedures, all subjects were assessed with the MoCA. The German version of the 
CERAD-NAB was administered at the end of the assessment to avoid possible 
interference effects with the MoCA. The MMSE was neither included in this 
CERAD-NAB version nor used to calculate the CERAD-NAB total score 
(Ehrensperger et al., 2010). Subjects meeting any exclusion criteria were omitted 
from the main statistical analysis only after all assessments took place. One out of 
four psychology master students who were specifically trained for the study 
examinations carried out the assessments. All assessments took place on one day 
during 1-2 hours and were held in a quiet room with subjects seated at a table. 
We used the official German translation of the MoCA (Version 7, November 2004; 
www.mocatest.org). The cognitive domains assessed are: (1) 
"Visuospatial/Executive", (2) "Naming", (3) "Memory", (4) "Attention", (5) 
"Language", (6) "Abstraction", (7) "Delayed Recall", and (8) "Orientation". The 
original version provides an extra point for individuals with lower education (i.e., ≤ 
12 years). Since we aimed at diligently correcting for education, we used the 
uncorrected MoCA total score in our calculations. 
 
3.2.3 Statistical analysis 
The effect of age, education, and sex on the MoCA total score was calculated using 
regression analysis. Twenty different general linear models were tested to adjust 
for the covariates age, education, and sex. A complete model search between a 
minimal and a maximal model was performed (Berres, Zehnder, Blasi, & Monsch, 
2008). The models included the quantitative covariates, the quantitative covariates’ 
squares, and their interactions with sex (see Supplementary Table 1 for details). 
The MoCA total score was transformed using a cubic transformation to achieve 
normality and homoscedasticity of the residuals. The initial 20 regression models 
were then recalculated with the transformed score, and the best model was 
selected. The best model was defined as the model with the minimum Predicted 
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Residual Sum of Squares (PRESS) statistic. This is a leave-one-out cross-
validation with PRESS = ∑(yi −  ŷi
(−i)
)2 where ŷi
(−i)
estimates the ith response from 
a model that was estimated without this observation (Berres et al., 2008). A smaller 
PRESS statistic indicates a higher predictive power of the corresponding model.  
The same model was selected before and after transformation, which corroborates 
the robustness of the method. In a last step, we checked for heterogeneity of 
variance of the residuals. The formula for the demographically corrected standard 
scores (z-scores) is based on the final regression model. Normative values were 
then calculated using the z-score formula. 
Sex differences in the MoCA total score were analyzed using the Mann-Whitney U-
Test. Spearman’s rank correlation for non-parametric data was used to investigate 
the associations between the MoCA, the CERAD-NAB, and the MMSE total scores. 
Kendall’s Tau for non-parametric data was used to test the associations between 
the demographic variables and the MoCA subdomains. Raw scores (i.e., not 
demographically corrected) were used in all analyses. 
The required sample size was 171 participants. This allows the estimation of the 
5th and the 95th percentile with no more than 2% deviation. Ten additional subjects 
were included per predictor variable (age, sex, education, and three expected 
interactions) to account for adjustments in the regression models. Thus, the 
minimum required sample size was 231 to account for all the predictor variables in 
the regression model (Jennen‐Steinmetz & Wellek, 2005). 
All statistical analyses were performed using R, version 3.4.1 (R Foundation, 
Vienna, Austria) and RStudio Desktop (RStudio, Boston, MA, USA). Data are 
presented as mean (SD), unless stated otherwise. 
 
3.3 RESULTS 
3.3.1 Descriptive analysis 
Two hundred and eighty-three cognitively healthy individuals (155 women, 128 
men) were included in the final analysis. Participants' mean age was 73.8 (5.2) 
years, ranging from 65 to 91 years. Education was 13.6 (2.9) years, ranging from 
7 to 20 years. The MoCA total score was 26.1 (2.5) points, and the MMSE total 
score was 29.2 (0.9) points. Detailed demographics are shown in Table 1. Medical 
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history and current medications of all subjects were assessed based on the medical 
questionnaire and are displayed in Table 2. 
 
Table 1. Demographic characteristics 
 
Data are presented as mean (SD). 
1Years of education was defined as the total number of years in school plus any 
professional education (not counting years needed to repeat). The maximum 
education was set at 20 years. In case of multiple specialized educations, only 
the longest one was counted. 
CERAD-NAB = Consortium to Establish a Registry for Alzheimer's Disease-
Neuropsychological Assessment Battery; GDS-15 = Geriatric Depression Scale 
(15 items); MMSE = Mini-Mental State Examination; MoCA = Montreal Cognitive 
Assessment. 
 
Table 2. Medical history and current medications 
 
Data are presented as n (%). 
1Mild head trauma with or without loss of consciousness < 5 minutes. 
2General anesthesia at least three months prior to study participation. 
3No current diagnosis of major depression and/or current psychotherapy for major 
depression. 
4Due to psychiatric diseases that occurred in the past (e.g., major depression). 
 
 
Table 1. Demographic characteristics 
 
Age 
group 
n 
Age, 
years 
Women, 
% 
Education1, 
years 
GDS-15 
total score 
CERAD-NAB 
total score 
MMSE 
total score 
MoCA 
total score 
65–69 68 67.6 (1.4) 61.8 13.2 (2.7) 0.3 (0.8) 97.9 (5.5) 29.4 (0.9) 26.6 (2.6) 
70–74 102 72.2 (1.3) 56.9 14.0 (2.9) 0.4 (0.7) 98.6 (5.2) 29.4 (0.7) 26.4 (2.4) 
75–79 68 76.5 (1.4) 50.0 13.7 (3.2) 0.3 (0.6) 99.5 (5.9) 29.3 (0.9) 25.8 (2.5) 
> 79 45 82.6 (2.4) 46.7 13.3 (2.8) 0.4 (0.7) 99.0 (6.5) 28.9 (1.0) 25.1 (2.4) 
Total 283 73.8 (5.2) 54.8 13.6 (2.9) 0.4 (0.7) 98.7 (5.7) 29.2 (0.9) 26.1 (2.5) 
 
Data are presented as mean (SD). 
 
1Years of education was defined as the total number of years in school plus any professional education 
(not counting years needed to repeat). The maximum education was set at 20 years. In case of multiple 
specialized educations, only the longest one was counted. 
 
CERAD-NAB = Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological 
Assessment Battery; GDS-15 = Geriatric Depression Scale (15 items); MMSE = Mini-Mental State 
Examination; MoCA = Montreal Cognitive Assessment. 
 
 
 
 
Table 2. Medical history and current medications 
 
Age 
group 
n 
History 
of head 
trauma1 
Prior 
general 
anesthesia2 
Prior 
diagnosis 
of major 
depr-
ession3 
Prior 
psychiatric 
hospitali-
zation4 
Regular 
alcohol 
consum-
ption5 
Oral 
anticoag
ulants/ 
antiplate
let drugs 
Anti-
hyper-
tensive 
drugs 
Statins 
Oral anti-
diabetic 
drugs 
65–69 68 5 (7.4) 59 (86.8) 3 (4.4) 1 (1.5) 45 (66.2) 5 (7.4) 20 (29.4) 14 (20.6) 4 (5.9) 
70–74 102 11 (10.8) 85 (83.3) 7 (6.9) 3 (2.9) 61 (59.8) 13 (12.7) 36 (35.3) 14 (13.7) 6 (5.9) 
75–79 68 5 (7.4) 56 (82.4) 0 (0) 1 (1.5) 49 (72.1) 17 (25.0) 31 (45.6) 18 (26.5) 1 (1.5) 
> 79 45 4 (8.9) 39 (86.7) 1 (2.2) 0 (0) 26 (57.8) 19 (42.2) 25 (55.6) 14 (31.1) 3 (6.7) 
Total 283 25 (8.8) 239 (84.5) 11 (3.9) 5 (1.7) 181 (64.0) 54 (19.1) 
112 
(39.6) 
60 (21.2) 14 (4.9) 
 
Data are presented as n (%). 
 
1Mild head trauma with or without loss of consciousness < 5 minutes. 
2General anesthesia at least three months prior to study participation. 
3No current diagnosis of major depression and/or current psychotherapy for major 
depression. 
4Due to psychiatric diseases that occurred in the past (e.g., major depression). 
5Participants answering the question: “Do you drink alcohol regularly?” with: “yes”. 
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5Participants answering the question: “Do you drink alcohol regularly?” with: “yes”. 
 
The MoCA total scores ranged from 15 to 30 points when corrected for education 
(Nasreddine et al., 2005). Their distribution is shown in Figure 2. Eighty-eight of the 
283 subjects (31.1%) scored below the cut-off score of < 26/30 points. The mean 
MoCA total score was higher for women than for men (26.3 (2.4) vs. 25.7 (2.6) 
points, p = 0.042). The rates of subjects with the maximum scores in subdomains 
were: "Visuospatial/Executive" = 50.2%, "Naming" = 99.3%, "Attention" = 76.0%, 
"Language" = 52.7%, "Abstraction" = 56.9%, "Delayed Recall" = 29.7%, and 
"Orientation" = 93.3%. The MoCA total score showed a moderate positive 
correlation with the CERAD-NAB total score (rs = 0.45, p < 0.001) and a weak 
positive correlation with the MMSE total score (rs = 0.20 p < 0.001). A weak positive 
correlation was also observed between MMSE and CERAD-NAB total scores (rs = 
0.23, p < 0.001). There were no missing values in any of the analyses. 
 
 
Fig. 2. Distribution of corrected MoCA total scores. The red line indicates the 
originally proposed MoCA cut-off (26/30 points). In our study, 88 subjects (31.1%) 
scored below this cut-off. 
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3.3.2 Demographic influences on the MoCA total score 
The MoCA total score was best predicted by a regression model with age, 
education, and sex (adjusted R² = 0.12, F = 14.2, p < 0.001), explaining 12% of the 
variance. In the regression analysis, increasing age (p < 0.001), less education (p 
< 0.001), and male sex (p = 0.003) were associated with a lower MoCA total score. 
The t-values indicate that this effect is strongest for education (t = 4.99), followed 
by age (t = -3.41), and sex (t = 3.02). The associations between the MoCA total 
score and demographic characteristics are shown in Figure 3. An analysis of the 
influence of demographic variables on the MoCA subdomains is presented in 
Supplementary Table 2. 
 
 
 
Fig. 3. Association of the MoCA total score with age, education, and sex. 
Exemplary regression lines are shown for 10 and 20 years of education, 
respectively. The regression model indicates that the MoCA total score is lower 
with increasing age and fewer years of education. Overall, female sex was 
associated with a higher MoCA total score than male sex. The areas in grey 
represent the 95% confidence intervals. 
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 3.3.3 Z-score calculation 
The z-scores are based on the formula: z = (transformed score - expected score) / 
residual standard deviation. A nearly normal distribution of the residuals was 
achieved using a cubic transformation of the raw MoCA total score. The formula for 
the demographically corrected z-score was derived from the final regression model. 
The z-score can be calculated as follows: z = MoCA total score3 - (23816.36 + (-
175.821 ∗ age) + (472.9053 ∗ education) + (1672.542 ∗ sex)) / 4470.258. Sex is 
coded as male = 0 and female = 1. Age and education are entered in integer values 
(years). We followed the example of Weintraub et al. (2018) and will provide a web-
based calculation tool (www.mocatest.ch) to automatically determine the z-score 
by entering the individual demographic data and MoCA total score.  
 
3.3.4 Cut-off scores 
Cut-off values were calculated based on the z-score formula (Table 3). The 
calculation was done separately for women and men for each year of age (65–91) 
and year of education (7–20). The cut-off was set at a z-score of ≤ -1.28 (10th 
percentile) to achieve 90% specificity. The applied percentiles may vary depending 
on the specific setting (e.g., screening in research or case-finding). We, therefore, 
chose to establish normative tables for the most common percentiles used. All cut-
off score tables (i.e., -1.64 SD [5th percentile], -1 SD [16th percentile], -1.5 SD [7th 
percentile], and -2 SD [2.5th percentile]) are provided in Supplementary Tables 3-
6. 
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Table 3. Highest MoCA total scores located just below the 10 th percentile 
(z-score < -1.28)  
The values correspond to the highest raw scores just below the 10 th percentile. 
For instance, a MoCA total score of 22 points is just below the 10 th percentile for 
a 65-year-old woman with 7 years of education. 
Note: The bonus point for individuals with ≤ 12 years of education must not be 
applied when using this cut-off score table. 
 
3.4 DISCUSSION 
Our study provides demographically corrected normative values (z-scores) for the 
German version of the MoCA. The MoCA total score was influenced by age, 
education, and sex, which is in line with previous normative studies of the MoCA 
(Borland et al., 2017; Konstantopoulos et al., 2016; Larouche et al., 2016) . Other 
studies found significant effects of age and education, but not for sex (Conti et al., 
2015; Freitas et al., 2011; Kenny et al., 2013; Kopecek et al., 2017; Lu et al., 2011; 
Malek-Ahmadi et al., 2015; Narazaki et al., 2013; Pereiro et al., 2017; Rossetti et 
al., 2011; Rossetti et al., 2017; Santangelo et al., 2015). While there is a basic 
adjustment for education in the original version (+ 1 point for education ≤ 12 years), 
our analyses provide a more precise correction for this important influencing factor. 
Moreover, we made necessary adjustments for age and sex, which are lacking in 
the original version. 
 
 
Table 3. Highest MoCA total scores located just below the 10th percentile (z-score < -1.28) 
 
 Women  
  Education (years)  
A
g
e
 (
y
e
a
rs
) 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20  
65 22 22 23 23 23 24 24 24 24 25 25 25 25 26 
66 22 22 23 23 23 24 24 24 24 25 25 25 25 26 
67 22 22 23 23 23 23 24 24 24 24 25 25 25 25 
68 22 22 22 23 23 23 24 24 24 24 25 25 25 25 
69 22 22 22 23 23 23 23 24 24 24 25 25 25 25 
70 22 22 22 23 23 23 23 24 24 24 24 25 25 25 
71 21 22 22 22 23 23 23 24 24 24 24 25 25 25 
72 21 22 22 22 23 23 23 23 24 24 24 24 25 25 
73 21 22 22 22 22 23 23 23 24 24 24 24 25 25 
74 21 21 22 22 22 23 23 23 24 24 24 24 25 25 
75 21 21 22 22 22 23 23 23 23 24 24 24 24 25 
76 21 21 22 22 22 22 23 23 23 24 24 24 24 25 
77 21 21 21 22 22 22 23 23 23 23 24 24 24 25 
78 21 21 21 22 22 22 23 23 23 23 24 24 24 24 
79 20 21 21 21 22 22 22 23 23 23 24 24 24 24 
80 20 21 21 21 22 22 22 23 23 23 23 24 24 24 
81 20 21 21 21 22 22 22 22 23 23 23 24 24 24 
82 20 20 21 21 21 22 22 22 23 23 23 24 24 24 
83 20 20 21 21 21 22 22 22 23 23 23 23 24 24 
84 20 20 20 21 21 22 22 22 22 23 23 23 24 24 
85 20 20 20 21 21 21 22 22 22 23 23 23 23 24 
86 19 20 20 21 21 21 22 22 22 23 23 23 23 24 
87 19 20 20 20 21 21 21 22 22 22 23 23 23 24 
88 19 20 20 20 21 21 21 22 22 22 23 23 23 23 
89 19 19 20 20 21 21 21 22 22 22 22 23 23 23 
90 19 19 20 20 20 21 21 21 22 22 22 23 23 23 
91 19 19 20 20 20 21 21 21 22 22 22 23 23 23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Men 
  Education (years) 
A
g
e
 (
y
e
a
rs
) 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
65 21 21 22 22 22 23 23 23 23 24 24 24 25 25 
66 21 21 22 22 22 22 23 23 23 24 24 24 24 25 
67 21 21 21 22 22 22 23 23 23 24 24 24 24 25 
68 21 21 21 22 22 22 23 23 23 23 24 24 24 24 
69 21 21 21 22 22 22 22 23 23 23 24 24 24 24 
70 20 21 21 21 22 22 22 23 23 23 24 24 24 24 
71 20 21 21 21 22 22 22 23 23 23 23 24 24 24 
72 20 20 21 21 21 22 22 22 23 23 23 24 24 24 
73 20 20 21 21 21 22 22 22 23 23 23 23 24 24 
74 20 20 21 21 21 22 22 22 23 23 23 23 24 24 
75 20 20 20 21 21 21 22 22 22 23 23 23 24 24 
76 20 20 20 21 21 21 22 22 22 23 23 23 23 24 
77 19 20 20 21 21 21 22 22 22 22 23 23 23 24 
78 19 20 20 20 21 21 21 22 22 22 23 23 23 24 
79 19 19 20 20 21 21 21 22 22 22 23 23 23 23 
80 19 19 20 20 20 21 21 22 22 22 22 23 23 23 
81 19 19 20 20 20 21 21 21 22 22 22 23 23 23 
82 19 19 19 20 20 21 21 21 22 22 22 23 23 23 
83 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
84 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
85 18 19 19 19 20 20 21 21 21 22 22 22 22 23 
86 18 18 19 19 20 20 20 21 21 21 22 22 22 23 
87 18 18 19 19 19 20 20 21 21 21 22 22 22 23 
88 18 18 19 19 19 20 20 20 21 21 22 22 22 22 
89 17 18 18 19 19 20 20 20 21 21 21 22 22 22 
90 17 18 18 19 19 19 20 20 21 21 21 22 22 22 
91 17 18 18 18 19 19 20 20 20 21 21 21 22 22 
 
 
The values correspond to the highest raw scores just below the 10th percentile. For instance, a 
MoCA total score of 22 points is just below the 10th percentile for a 65-year-old woman with 7 
years of education. 
 
Note: The bonus point for indivduals with ≤12 years of education must not be applied when using 
this cut-off score table. 
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Considering these demographic influences will likely improve the diagnostic 
accuracy of the MoCA. For instance, in our sample of cognitively healthy 
participants, 88 subjects (31.1%) scored below the originally proposed cut-off score 
of 26 points (Nasreddine et al., 2005), even when the bonus point was given for 
individuals with ≤ 12 years of education. The demographically corrected cut-off 
values provided in our study may reduce this false-positive rate. For example, a 
MoCA total score of 23 in an 85-year-old man (hypothetical patient 1) with 8 years 
of education is considered to be pathological according to the originally 
recommended cut-off score, even if one point would be added due to education ≤ 
12 years. However, his demographically corrected z-score (based on our study) is 
-0.11, which is still considered to be within normal limits. In contrast, a MoCA total 
score of 26 points in a 65-year-old woman (hypothetical patient 2) with 20 years of 
education is considered to be within normal limits. Yet, her demographically 
corrected z-score (based on our study) is -1.33, which is below the 10th percentile 
and, therefore, pathological. These two examples illustrate that using 
demographically adjusted normative values lead to a decrease of false-positive 
(hypothetical patient 1) and false-negative results (hypothetical patient 2), 
respectively. 
In our analysis, 12% of the variance in the MoCA total score was explained by 
demographic characteristics, while other authors reported an explained variance 
up to 49% (Freitas et al., 2011). This discrepancy is likely due to the much larger 
age range in some studies. Because both age and education influence cognitive 
performance, the variance increases when age or education ranges are broad. 
Consequently, including these variables in a regression model will explain more of 
the variance. When paralleling our findings to a study with a smaller age range 
(Borland et al., 2017), results are very comparable (R² = 0.11). 
In our study, the correlation between the MoCA and CERAD-NAB total scores was 
much higher than the correlation between the MMSE and CERAD-NAB total 
scores. This suggests that the MoCA assesses cognition in a more comprehensive 
way compared to the MMSE. Twenty-eight excluded subjects scored below the cut-
off on the CERAD-NAB, but still had an MMSE score ≥ 27 points, supporting the 
notion that the MMSE lacks sensitivity for detection of MCI. In this context, a recent 
report by Chapman et al. (2016) indicates that the MMSE might be unsuitable to 
define eligibility for AD clinical trials. There is a clear need for a cognitive screening 
tool with high diagnostic accuracy for subject enrollment in AD studies. Future 
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studies may verify whether the MoCA (used with appropriate norms) is more 
suitable to determine subject selection. 
 
3.4.1 Comparison with international normative samples 
In recent years, several research groups conducted normative studies for the 
MoCA in different languages. An overview of the existing literature is provided in 
Table 4. The majority of these reports suggest that the originally proposed MoCA 
cut-off score of 26 points is too conservative. Nine out of 14 normative studies 
reported a mean MoCA total score < 26 points in their sample (Abou-Mrad et al., 
2017; Conti et al., 2015; Freitas et al., 2011; Kopecek et al., 2017; Malek-Ahmadi 
et al., 2015; Narazaki et al., 2013; Rossetti et al., 2011; Rossetti et al., 2017; 
Santangelo et al., 2015). In general, studies reported the mean MoCA total score 
without the one-point correction for education; one study did not mention whether 
the correction was applied (Freitas et al., 2011). When applying the bonus point for 
education, nearly one-third of our sample scored below the cut-off of 26 points. 
Previous normative studies using the original cut-off score reported false-positive 
rates of 46% (Malek-Ahmadi et al., 2015) up to 76% (Rossetti et al., 2017). 
There are several explanations for these high false-positive rates and their 
substantial variation between studies. First, the MoCA total score might be 
influenced by intercultural and language differences (e.g., socioeconomic or 
sociodemographic factors, different word lengths originating from translations 
[Kopecek et al., 2017; Lu et al., 2011; Rossetti et al., 2017; Strauss, Sherman, & 
Spreen, 2006]). One study suggests that ethnicity may influence the MoCA total 
score (Rossetti et al., 2017). However, this may be explained by disparities in 
socioeconomic factors (e.g., quality of education) rather than ethnicity itself 
(Strauss et al., 2006). Second, there are important differences in sample sizes, 
ranging from n = 90 (Nasreddine et al., 2005) to n = 6,283 (Lu et al., 2011). Larger 
samples may better represent the general population and decrease the risk of 
sampling errors (Strauss et al., 2006). Yet, even large studies may have small cell 
sizes, when distinct subgroups (e.g., age categories) are defined to create norms. 
Third, not all studies were intended as normative studies, and data may have been 
collected for other purposes (Borland et al., 2017; Larouche et al., 2016; Malek-
Ahmadi et al., 2015; Narazaki et al., 2013; Pereiro et al., 2017; Rossetti et al., 2011; 
Rossetti et al., 2017). These "samples of convenience" may lack appropriate 
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inclusion/exclusion criteria and standard procedures in MoCA administration, 
leading to increased variability within samples, especially if data are gathered from 
multiple centers (Strauss et al., 2006). Fourth, there are substantial dissimilarities 
in the demographic characteristics of study participants. Mean age differs by almost 
40 years between the youngest (Konstantopoulos et al., 2016) and the oldest 
sample (Malek-Ahmadi et al., 2015). Large variances can also be seen in mean 
education, ranging from 8.2 (4.7) (Freitas et al., 2011) to 14.4 (3.8) (Larouche et 
al., 2016) years. Considering the effects of these demographic characteristics on 
the MoCA performance, differences in mean age or education possibly lead to 
variances in the mean MoCA total score among studies. Finally, normative studies 
diverge regarding inclusion/exclusion criteria (Borland et al., 2017; Narazaki et al., 
2013; Nasreddine et al., 2012). Cognitive health of participants is of utmost 
importance in normative studies, particularly if subtle cognitive changes should be 
detected. In some normative studies, cognition was assessed using methods that 
might not be sensitive enough to detect subtle cognitive impairment (Kenny et al., 
2013; Rossetti et al., 2011; Rossetti et al., 2017). Other investigators did not screen 
for cognitive impairment at all (Narazaki et al., 2013). 
3.4.2 Cognitive health in normative samples 
There are two different methodological approaches to normative studies. One is to 
rely on a population-based sample to create norms; for the other, a sample of 
indisputably healthy volunteers is chosen. Both methods bear the risk of inducing 
bias: while the former is prone to false-negative errors, the latter is prone to false-
positive ones (Strauss et al., 2006). In our study, we chose the latter approach and 
applied stringent criteria to assure cognitive health of the participants. One might 
argue that such rigorous exclusion criteria may lead to a sample of "supernormal" 
individuals. However, the population-based approach does not seem appropriate 
when normative data are collected for an elderly population. Since the incidence 
and prevalence of MCI increases with age (Petersen et al., 2017), the probability 
of erroneously including individuals suffering from a cognitive disorder increases 
as well. Including cognitively impaired individuals in a normative group lowers the 
reference range for cognitive health, and the distinction between the two groups 
(MCI vs. healthy individuals) will be less clear. Consequently, it is very likely that 
the sensitivity for the detection of MCI decreases when relying on a population-
based approach. Thus, we consider the criteria of indisputable cognitive health as 
a mandatory prerequisite for normative data. 
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Table 4. Overview of international normative data for the MoCA 
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3.4.3 Strengths and limitations 
A regression-based approach yields some important advantages over the 
traditional norming method (i.e., reference ranges for cells of age and/or education 
groups). First, in traditional norming the sample is divided into subgroups. This 
leads to relatively small sample sizes per group, even if the overall sample size is 
quite large (Berres et al., 2008). In contrast, regression-based norming considers 
the whole sample, and the continuous variables (i.e., age and education) are 
analyzed in their full range. Second, relying on age and/or education groups to 
create norms may misrepresent individuals who are situated close to the boundary 
of a subgroup (Larouche et al., 2016). Moreover, due to the more or less arbitrarily 
chosen subgroup boundaries, traditional norming may not properly reflect the 
natural development of cognitive performance (Strauss et al., 2006). The 
regression-based approach, however, considers the overall trend in the data. Third, 
the regression-based approach allows to simultaneously study multiple covariates 
and their potential interactions.  
We acknowledge some limitations of our study. First, there may be a selection bias 
as our participants were recruited from an existing registry of individuals interested 
in taking part in research projects. These individuals may potentially show a greater 
motivation to perform well in cognitive testing than the average population. 
Individuals who participated in this study completed the Swiss educational system. 
Although the educational system in Switzerland is not 100% equal to the 
educational systems in other German-speaking countries, we believe that the 
acquired normative data are suitable for German-speaking populations in general. 
Our norms are intended for the elderly population and cannot be applied to 
individuals younger than 65 years. Second, cognitive test performance is commonly 
adjusted for demographic influences. Yet, some authors question if demographic 
adjustments are appropriate in dementia diagnostics, because age and education 
are known risk factors for cognitive impairment (Narazaki et al., 2013; Strauss et 
al., 2006). O'Connell and Tuokko (2010) found that the overall diagnostic accuracy 
is comparable for raw versus adjusted scores. While having lower sensitivity, the 
adjusted scores were shown to have better specificity. As our results show, MoCA 
performance declines with older age and/or lower education (Table 2). Therefore, 
when using a simple cut-off, the rate of false-positives may be higher with 
increasing age and/or lower education. Thus, adjusted scores may be more 
appropriate if the MoCA is used for diagnostic purposes in elderly individuals. 
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Our aim was to enhance the sensitivity of the MoCA by excluding any individuals 
with signs of cognitive impairment. In addition, specificity likely increases when 
applying a demographic adjustment of the obtained total score. However, the 
current normative data are not suitable to determine the exact diagnostic accuracy 
of the German MoCA. This version of the MoCA must first be validated in cognitively 
impaired patients, which is a follow-up project. 
 
3.5 CONCLUSIONS 
This study provides normative values for the German version of the MoCA. Our 
findings support the frequent statement that the originally proposed cut-off score 
may be too conservative. The MoCA performance was influenced by age, 
education and, – less consistently – by sex in all available studies, including ours. 
Thus, using demographically adjusted norms will improve the diagnostic accuracy 
of the MoCA. In addition, we observed a high level of heterogeneity in the 
methodology of existing normative studies. Therefore, we strongly suggest an 
international harmonization of guidelines for normative studies to enhance 
comparability in the future. 
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Supplementary material 
 
Supplementary Table 1. Twenty regression models 
 
A = age; AS = (age - mean age) * sex; A2 = (age - mean age)2; E = education;         
ES = (education - mean education) * sex; E2 = (education - mean education)2;              
S = sex. 
 
Supplementary Table 2. Correlations (Kendall’s Tau) between demographical 
variables and MoCA subdomains 
 
* p < 0.05; ** p < 0.005; *** p < 0.001 
 
 
 
 
 
 
 
 
Supplementary Table 1. Twenty regression models
 
Basic models + square of age + square of education 
+ square of age + square of 
education 
A + E A + E + A2 A + E + E2 A + E + A2 + E2 
A + E + S  A + E + S + A2 A + E + S + E2 A + E + S + A2 + E2 
A + E + S + AS A + E + S + AS + A2 A + E + S + AS + E2 A + E + S + AS + A2 + E2 
A + E + S + ES A + E + S + ES + A2 A + E + S + ES + E2 A + E + S + ES + A2 + E2 
A + E + S + AS + ES  A + E + S + AS + ES + A2 A + E + S + AS + ES + E2 A + E + S + AS + ES + A2 + E2 
 
A = age; AS = (age - mean age) ≤ sex; A2 = (age - mean age)2; E = education; ES = (education 
- mean education) ≤ sex; E2 = (education - mean education)2; S = sex.  
 
Supplementary Table 2. Correlations (Kendall’s Tau) between demographical variables and 
MoCA subdomains 
 
 Age Education Female sex 
Visuospatial/Executive -0.11* 0.22*** -0.16* 
Naming 0.00 0.07 -0.08 
Attention -0.08 0.10 -0.03 
Language -0.02 0.15** 0.15* 
Abstraction -0.03 0.17*** 0.04 
Delayed Recall -0.12* 0.03 0.17** 
Orientation 0.03 -0.03 0.04 
MoCA total score -0.15*** 0.19*** 0.11* 
 
*p < 0.05; **p < 0.005; ***p < 0.001. 
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Supplementary Table 3. Highest MoCA total scores located just below the 5th 
percentile 
 
The values presented correspond to the highest raw scores just below the 5 th 
percentile. For instance, a MoCA total score of 21 points is just below the 5 th 
percentile for a 65-year-old woman with 7 years of education. Note: The bonus 
point for individuals with ≤ 12 years of education must not be applied when using 
this normative table. 
 
Supplementary Table 4. Highest MoCA total scores located just below -1 SD 
(16th percentile) 
 
The values presented correspond to the highest raw scores just below -1 SD. For 
instance, a MoCA total score of 23 points is just below -1 SD for a 65-year-old 
woman with 7 years of education. Note: The bonus point for individuals with ≤ 12 
years of education must not be applied when using this normative table. 
 
 
Supplementary Table 3. Highest MoCA total scores located just below the 5th percentile (z-score < -1.64) 
 
 Women   Men 
  Education (years)    Education (years) 
A
ge
 (
ye
ar
s)
 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20  
A
ge
 (
ye
ar
s)
 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
65 21 21 22 22 22 23 23 23 23 24 24 24 25 25 65 20 20 21 21 21 22 22 22 22 23 23 23 24 24 
66 21 21 22 22 22 23 23 23 23 24 24 24 24 25 66 20 20 20 21 21 21 22 22 22 23 23 23 24 24 
67 21 21 21 22 22 22 23 23 23 24 24 24 24 25 67 20 20 20 21 21 21 22 22 22 23 23 23 23 24 
68 21 21 21 22 22 22 23 23 23 23 24 24 24 25 68 19 20 20 20 21 21 22 22 22 22 23 23 23 24 
69 21 21 21 22 22 22 23 23 23 23 24 24 24 24 69 19 20 20 20 21 21 21 22 22 22 23 23 23 23 
70 20 21 21 21 22 22 22 23 23 23 24 24 24 24 70 19 19 20 20 21 21 21 22 22 22 23 23 23 23 
71 20 21 21 21 22 22 22 23 23 23 23 24 24 24 71 19 19 20 20 20 21 21 21 22 22 22 23 23 23 
72 20 21 21 21 22 22 22 22 23 23 23 24 24 24 72 19 19 20 20 20 21 21 21 22 22 22 23 23 23 
73 20 20 21 21 21 22 22 22 23 23 23 24 24 24 73 19 19 19 20 20 21 21 21 22 22 22 22 23 23 
74 20 20 21 21 21 22 22 22 23 23 23 23 24 24 74 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
75 20 20 20 21 21 21 22 22 22 23 23 23 24 24 75 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
76 20 20 20 21 21 21 22 22 22 23 23 23 23 24 76 18 19 19 19 20 20 21 21 21 22 22 22 22 23 
77 19 20 20 21 21 21 22 22 22 23 23 23 23 24 77 18 18 19 19 20 20 20 21 21 21 22 22 22 23 
78 19 20 20 20 21 21 21 22 22 22 23 23 23 24 78 18 18 19 19 19 20 20 21 21 21 22 22 22 23 
79 19 20 20 20 21 21 21 22 22 22 23 23 23 23 79 18 18 18 19 19 20 20 20 21 21 21 22 22 22 
80 19 19 20 20 21 21 21 22 22 22 22 23 23 23 80 17 18 18 19 19 20 20 20 21 21 21 22 22 22 
81 19 19 20 20 20 21 21 21 22 22 22 23 23 23 81 17 18 18 19 19 19 20 20 21 21 21 22 22 22 
82 19 19 19 20 20 21 21 21 22 22 22 23 23 23 82 17 18 18 18 19 19 20 20 20 21 21 21 22 22 
83 19 19 19 20 20 20 21 21 22 22 22 22 23 23 83 17 17 18 18 19 19 20 20 20 21 21 21 22 22 
84 18 19 19 20 20 20 21 21 21 22 22 22 23 23 84 17 17 18 18 19 19 19 20 20 21 21 21 22 22 
85 18 19 19 19 20 20 21 21 21 22 22 22 23 23 85 16 17 17 18 18 19 19 20 20 20 21 21 21 22 
86 18 18 19 19 20 20 20 21 21 21 22 22 22 23 86 16 17 17 18 18 19 19 19 20 20 21 21 21 22 
87 18 18 19 19 20 20 20 21 21 21 22 22 22 23 87 16 17 17 18 18 19 19 19 20 20 20 21 21 21 
88 18 18 19 19 19 20 20 21 21 21 22 22 22 22 88 16 16 17 17 18 18 19 19 20 20 20 21 21 21 
89 17 18 18 19 19 20 20 20 21 21 21 22 22 22 89 16 16 17 17 18 18 19 19 19 20 20 21 21 21 
90 17 18 18 19 19 20 20 20 21 21 21 22 22 22 90 15 16 17 17 18 18 18 19 19 20 20 20 21 21 
91 17 18 18 19 19 19 20 20 20 21 21 22 22 22 91 15 16 16 17 17 18 18 19 19 20 20 20 21 21 
 
 
Supplementary Table 4. Highest MoCA total scores located just below -1 SD (16th percentile) 
 
 Women   Men 
  Education (years)    Education (years) 
A
ge
 (
ye
a
rs
) 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20  
A
ge
 (
ye
a
rs
) 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
65 23 23 24 24 24 24 25 25 25 25 26 26 26 26 65 22 22 23 23 23 23 24 24 24 24 25 25 25 25 
66 23 23 23 24 24 24 24 25 25 25 25 26 26 26 66 22 22 22 23 23 23 24 24 24 24 25 25 25 25 
67 23 23 23 24 24 24 24 25 25 25 25 26 26 26 67 22 22 22 23 23 23 23 24 24 24 24 25 25 25 
68 23 23 23 23 24 24 24 25 25 25 25 25 26 26 68 22 22 22 22 23 23 23 24 24 24 24 25 25 25 
69 23 23 23 23 24 24 24 24 25 25 25 25 26 26 69 21 22 22 22 23 23 23 24 24 24 24 25 25 25 
70 22 23 23 23 24 24 24 24 25 25 25 25 26 26 70 21 22 22 22 23 23 23 23 24 24 24 24 25 25 
71 22 23 23 23 23 24 24 24 25 25 25 25 25 26 71 21 21 22 22 22 23 23 23 24 24 24 24 25 25 
72 22 22 23 23 23 24 24 24 24 25 25 25 25 26 72 21 21 22 22 22 23 23 23 23 24 24 24 25 25 
73 22 22 23 23 23 24 24 24 24 25 25 25 25 26 73 21 21 22 22 22 23 23 23 23 24 24 24 24 25 
74 22 22 23 23 23 23 24 24 24 24 25 25 25 25 74 21 21 21 22 22 22 23 23 23 24 24 24 24 25 
75 22 22 22 23 23 23 24 24 24 24 25 25 25 25 75 21 21 21 22 22 22 23 23 23 23 24 24 24 24 
76 22 22 22 23 23 23 23 24 24 24 25 25 25 25 76 21 21 21 22 22 22 22 23 23 23 24 24 24 24 
77 22 22 22 23 23 23 23 24 24 24 24 25 25 25 77 20 21 21 21 22 22 22 23 23 23 24 24 24 24 
78 21 22 22 22 23 23 23 24 24 24 24 25 25 25 78 20 21 21 21 22 22 22 23 23 23 23 24 24 24 
79 21 22 22 22 23 23 23 23 24 24 24 25 25 25 79 20 20 21 21 22 22 22 22 23 23 23 24 24 24 
80 21 22 22 22 22 23 23 23 24 24 24 24 25 25 80 20 20 21 21 21 22 22 22 23 23 23 23 24 24 
81 21 21 22 22 22 23 23 23 24 24 24 24 25 25 81 20 20 21 21 21 22 22 22 23 23 23 23 24 24 
82 21 21 22 22 22 23 23 23 23 24 24 24 24 25 82 20 20 20 21 21 21 22 22 22 23 23 23 24 24 
83 21 21 22 22 22 22 23 23 23 24 24 24 24 25 83 20 20 20 21 21 21 22 22 22 23 23 23 23 24 
84 21 21 21 22 22 22 23 23 23 23 24 24 24 25 84 19 20 20 21 21 21 22 22 22 22 23 23 23 24 
85 21 21 21 22 22 22 23 23 23 23 24 24 24 24 85 19 20 20 20 21 21 21 22 22 22 23 23 23 24 
86 20 21 21 21 22 22 22 23 23 23 24 24 24 24 86 19 20 20 20 21 21 21 22 22 22 23 23 23 23 
87 20 21 21 21 22 22 22 23 23 23 23 24 24 24 87 19 19 20 20 20 21 21 22 22 22 22 23 23 23 
88 20 21 21 21 22 22 22 23 23 23 23 24 24 24 88 19 19 20 20 20 21 21 21 22 22 22 23 23 23 
89 20 20 21 21 21 22 22 22 23 23 23 24 24 24 89 19 19 19 20 20 21 21 21 22 22 22 23 23 23 
90 20 20 21 21 21 22 22 22 23 23 23 23 24 24 90 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
91 20 20 21 21 21 22 22 22 22 23 23 23 24 24 91 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
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Supplementary Table 5. Highest MoCA total scores located just below -1.5 SD 
(7th percentile) 
 
The values presented correspond to the highest raw scores just below -1.5 SD. 
For instance, a MoCA total score of 22 points is just below -1.5 SD for a 65-year-
old woman with 7 years of education. Note: The bonus point for individuals with ≤ 
12 years of education must not be applied when using this normative table. 
 
Supplementary Table 6. Highest MoCA total scores located just below -2 SD 
(2.5th percentile) 
 
The values presented correspond to the highest raw scores just below -2 SD. For 
instance, a MoCA total score of 20 points is just below -2 SD for a 65-year-old 
woman with 7 years of education. Note: The bonus point for individuals with ≤ 12 
years of education must not be applied when using this normative table. 
 
 
Supplementary Table 5. Highest MoCA total scores located just below -1.5 SD (7th percentile) 
 
 Women   Men 
  Education (years)    Education (years) 
A
ge
 (
ye
ar
s)
 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20  
A
ge
 (
ye
ar
s)
 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
65 22 22 22 22 23 23 23 24 24 24 24 25 25 25 65 20 21 21 21 22 22 22 23 23 23 23 24 24 24 
66 21 22 22 22 23 23 23 23 24 24 24 25 25 25 66 20 21 21 21 22 22 22 22 23 23 23 24 24 24 
67 21 22 22 22 23 23 23 23 24 24 24 24 25 25 67 20 20 21 21 21 22 22 22 23 23 23 24 24 24 
68 21 21 22 22 22 23 23 23 24 24 24 24 25 25 68 20 20 21 21 21 22 22 22 23 23 23 23 24 24 
69 21 21 22 22 22 23 23 23 23 24 24 24 25 25 69 20 20 20 21 21 22 22 22 22 23 23 23 24 24 
70 21 21 22 22 22 22 23 23 23 24 24 24 24 25 70 20 20 20 21 21 21 22 22 22 23 23 23 23 24 
71 21 21 21 22 22 22 23 23 23 24 24 24 24 25 71 19 20 20 21 21 21 22 22 22 23 23 23 23 24 
72 21 21 21 22 22 22 23 23 23 23 24 24 24 24 72 19 20 20 20 21 21 21 22 22 22 23 23 23 24 
73 20 21 21 22 22 22 22 23 23 23 24 24 24 24 73 19 20 20 20 21 21 21 22 22 22 23 23 23 23 
74 20 21 21 21 22 22 22 23 23 23 23 24 24 24 74 19 19 20 20 21 21 21 22 22 22 22 23 23 23 
75 20 21 21 21 22 22 22 23 23 23 23 24 24 24 75 19 19 20 20 20 21 21 21 22 22 22 23 23 23 
76 20 20 21 21 21 22 22 22 23 23 23 24 24 24 76 19 19 20 20 20 21 21 21 22 22 22 23 23 23 
77 20 20 21 21 21 22 22 22 23 23 23 23 24 24 77 19 19 19 20 20 20 21 21 22 22 22 22 23 23 
78 20 20 21 21 21 22 22 22 22 23 23 23 24 24 78 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
79 20 20 20 21 21 21 22 22 22 23 23 23 24 24 79 18 19 19 19 20 20 21 21 21 22 22 22 23 23 
80 20 20 20 21 21 21 22 22 22 23 23 23 23 24 80 18 18 19 19 20 20 20 21 21 21 22 22 22 23 
81 19 20 20 21 21 21 22 22 22 22 23 23 23 24 81 18 18 19 19 20 20 20 21 21 21 22 22 22 23 
82 19 20 20 20 21 21 21 22 22 22 23 23 23 24 82 18 18 19 19 19 20 20 21 21 21 22 22 22 22 
83 19 19 20 20 21 21 21 22 22 22 23 23 23 23 83 17 18 18 19 19 20 20 20 21 21 21 22 22 22 
84 19 19 20 20 20 21 21 21 22 22 22 23 23 23 84 17 18 18 19 19 20 20 20 21 21 21 22 22 22 
85 19 19 20 20 20 21 21 21 22 22 22 23 23 23 85 17 18 18 19 19 19 20 20 20 21 21 22 22 22 
86 19 19 19 20 20 21 21 21 22 22 22 23 23 23 86 17 17 18 18 19 19 20 20 20 21 21 21 22 22 
87 18 19 19 20 20 20 21 21 21 22 22 22 23 23 87 17 17 18 18 19 19 19 20 20 21 21 21 22 22 
88 18 19 19 20 20 20 21 21 21 22 22 22 23 23 88 17 17 18 18 18 19 19 20 20 20 21 21 21 22 
89 18 19 19 19 20 20 21 21 21 22 22 22 22 23 89 16 17 17 18 18 19 19 20 20 20 21 21 21 22 
90 18 18 19 19 20 20 20 21 21 21 22 22 22 23 90 16 17 17 18 18 19 19 19 20 20 21 21 21 22 
91 18 18 19 19 19 20 20 21 21 21 22 22 22 23 91 16 16 17 18 18 18 19 19 20 20 20 21 21 21 
 
 
Supplementary Table 6. Highest MoCA total scores located just below -2 SD (2.5th percentile) 
 
 Women   Men 
  Education (years)    Education (years) 
A
ge
 (
ye
ar
s)
 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20  
A
ge
 (
ye
ar
s)
 
 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
65 20 20 21 21 21 22 22 22 23 23 23 23 24 24 65 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
66 20 20 20 21 21 21 22 22 22 23 23 23 24 24 66 18 19 19 20 20 20 21 21 21 22 22 22 23 23 
67 20 20 20 21 21 21 22 22 22 23 23 23 23 24 67 18 19 19 19 20 20 20 21 21 22 22 22 22 23 
68 19 20 20 21 21 21 22 22 22 22 23 23 23 24 68 18 18 19 19 20 20 20 21 21 21 22 22 22 23 
69 19 20 20 20 21 21 21 22 22 22 23 23 23 24 69 18 18 19 19 19 20 20 21 21 21 22 22 22 23 
70 19 20 20 20 21 21 21 22 22 22 23 23 23 23 70 18 18 18 19 19 20 20 20 21 21 21 22 22 22 
71 19 19 20 20 21 21 21 22 22 22 22 23 23 23 71 17 18 18 19 19 20 20 20 21 21 21 22 22 22 
72 19 19 20 20 20 21 21 21 22 22 22 23 23 23 72 17 18 18 19 19 19 20 20 21 21 21 22 22 22 
73 19 19 19 20 20 21 21 21 22 22 22 23 23 23 73 17 17 18 18 19 19 20 20 20 21 21 21 22 22 
74 18 19 19 20 20 20 21 21 21 22 22 22 23 23 74 17 17 18 18 19 19 20 20 20 21 21 21 22 22 
75 18 19 19 20 20 20 21 21 21 22 22 22 23 23 75 17 17 18 18 19 19 19 20 20 20 21 21 22 22 
76 18 19 19 19 20 20 21 21 21 22 22 22 23 23 76 16 17 17 18 18 19 19 20 20 20 21 21 21 22 
77 18 18 19 19 20 20 20 21 21 21 22 22 22 23 77 16 17 17 18 18 19 19 19 20 20 21 21 21 22 
78 18 18 19 19 20 20 20 21 21 21 22 22 22 23 78 16 17 17 18 18 18 19 19 20 20 20 21 21 21 
79 18 18 19 19 19 20 20 21 21 21 22 22 22 22 79 16 16 17 17 18 18 19 19 20 20 20 21 21 21 
80 17 18 18 19 19 20 20 20 21 21 21 22 22 22 80 16 16 17 17 18 18 19 19 19 20 20 21 21 21 
81 17 18 18 19 19 19 20 20 21 21 21 22 22 22 81 15 16 16 17 18 18 18 19 19 20 20 20 21 21 
82 17 18 18 19 19 19 20 20 20 21 21 21 22 22 82 15 16 16 17 17 18 18 19 19 20 20 20 21 21 
83 17 17 18 18 19 19 20 20 20 21 21 21 22 22 83 15 15 16 17 17 18 18 19 19 19 20 20 21 21 
84 17 17 18 18 19 19 19 20 20 21 21 21 22 22 84 15 15 16 16 17 17 18 18 19 19 20 20 20 21 
85 17 17 18 18 18 19 19 20 20 20 21 21 21 22 85 14 15 16 16 17 17 18 18 19 19 19 20 20 21 
86 16 17 17 18 18 19 19 20 20 20 21 21 21 22 86 14 15 15 16 17 17 18 18 18 19 19 20 20 20 
87 16 17 17 18 18 19 19 19 20 20 21 21 21 22 87 14 14 15 16 16 17 17 18 18 19 19 20 20 20 
88 16 16 17 17 18 18 19 19 20 20 20 21 21 21 88 13 14 15 16 16 17 17 18 18 19 19 19 20 20 
89 16 16 17 17 18 18 19 19 19 20 20 21 21 21 89 13 14 15 15 16 16 17 18 18 18 19 19 20 20 
90 15 16 17 17 18 18 19 19 19 20 20 20 21 21 90 13 14 14 15 16 16 17 17 18 18 19 19 20 20 
91 15 16 16 17 17 18 18 19 19 20 20 20 21 21 91 12 13 14 15 15 16 17 17 18 18 19 19 19 20 
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Supplementary Fig. 1. English translation of the medical questionnaire. 
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4. Study II: 
Two separate cut-offs on the MoCA for patients with a 
neurocognitive disorder 
Alessandra E. Thomanna,b, Manfred Berresc, Nicolai Goettelb,d, Luzius A. Steinerb,d, 
and Andreas U. Monscha 
Submitted 
aMemory Clinic, University Department of Geriatric Medicine FELIX PLATTER, Basel, 
Switzerland 
bAnesthesiology, University Hospital Basel, Switzerland 
cDepartment of Mathematics and Technology, University of Applied Sciences 
Koblenz, Koblenz, Germany 
dDepartment of Clinical Research, University of Basel, Switzerland 
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ABSTRACT 
Introduction: The Montreal Cognitive Assessment (MoCA) has good sensitivity for 
mild cognitive impairment, but specificity is low when the original cut-off is used. 
We aim to revise the cut-off on the German MoCA for its use in clinical routine. 
Methods: Data were analyzed from 496 Memory Clinic outpatients (447 individuals 
with a neurocognitive disorder; 49 with cognitive normal findings) and from 283 
normal controls. Cut-offs were identified based on (1) the Youden’s index and (2) 
the 10th percentile of the control group. 
Results: Compared to the original, a cut-off of 23/24 points had higher specificity 
(92% vs 63%), but lower sensitivity (65% vs 86%). Introducing two separate cut-
offs increased diagnostic accuracies with 92% specificity (23/24 points) and 91% 
sensitivity (26/27 points). Scores between these two cut-offs require further 
examinations. 
Discussion: Using two separate cut-offs for the MoCA combined with scores in a 
gray area enhances the accuracy of cognitive screening. 
 
Keywords: Sensitivity and Specificity; Neuropsychology; Mental Status and 
Dementia Tests; Montreal Cognitive Assessment; Mini Mental State Examination; 
Neurocognitive Disorders; ROC Curve; Cognitive Dysfunction; Area Under Curve 
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4.1 BACKGROUND 
A steep increase in the prevalence of dementia is expected (Prince et al., 2016) 
and early detection of cognitive decline is crucial (Yaffe, 2018). The implementation 
of therapeutic strategies depends on a successful case-finding process at the 
general practitioners’ office and reliable screening tools are required (Ehrensperger 
et al., 2014). In addition, accurate cognitive assessment allows for an adequate 
selection of participants in clinical research, since erroneous inclusion or exclusion 
of individuals may bias study findings (Edmonds et al., 2018; Edmonds et al., 2016).  
The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) has gained 
popularity for cognitive screening. It correlates well with extensive 
neuropsychological test batteries (Lam et al., 2013; Thomann, Goettel, Monsch, et 
al., 2018) and covers most of the cognitive domains outlined in the Diagnostic and 
Statistical Manual, 5th Edition (DSM-5; American Psychiatric Association, 2013). 
However, while the initially proposed cut-off (25/26 points; Nasreddine et al., 2005) 
has shown good sensitivity for mild cognitive impairment (MCI) (Ozer et al., 2016; 
Trzepacz et al., 2015), this cut-off may lead to an unacceptably high number of 
false-positive classifications (Carson et al., 2018; Davis et al., 2015; Thomann, 
Goettel, Monsch, et al., 2018). Consequently, new cut-offs have been proposed for 
various patient populations and languages (see Carson et al. , 2018 for an 
overview).  
The properties of any screening test are not fixed characteristics, but depend on 
the clinical context (Florkowski, 2008), limiting the transferability of findings to other 
settings. Moreover, optimal cut-offs are likely to be specific to the individual study 
(Martin, Schroeder, & Baade, 2017; Weissberger et al., 2017) and should be 
validated in independent samples. In clinical practice, patient populations are 
typically heterogeneous, and medical comorbidities are frequent. In most validation 
studies, a rather homogenous patient sample was recruited (e.g., only patients with 
probable Alzheimer’s disease [AD] according to McKhann-Criteria; McKhann et al., 
2011), exclusion of patients with medical comorbidities). Excluding patients who 
are difficult to diagnose induces several forms of bias and may lead to an 
overestimation of diagnostic accuracy (Lijmer et al., 1999; Noel-Storr et al., 2014). 
Heterogeneous samples reflect the clinical reality more accurately as health care 
professionals face the challenge to identify truly impaired patients from a pool of 
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individuals with a suspected neurocognitive disorder (NCD), irrespective of its 
underlying cause. 
In the present study, we estimate the diagnostic accuracy of the original MoCA cut-
off in consecutive Memory Clinic outpatients (MC sample) to differentiate normal 
findings (NF; i.e., neurocognitive results were within normal limits) from patients 
with mild and major NCD (labelled Mild+Major NCD in the following). Since the 
MoCA was developed to identify individuals with MCI, subgroup analyses are 
performed for patients diagnosed with mild NCD (labelled Mild NCD in the 
following). Given the high rate of false-positive classifications that is associated 
with the original MoCA cut-off, we aimed at finding a new cut-off with higher 
specificity. In this context, we introduce a novel approach to determine a cut-off 
solely based on a sample of cognitively healthy normal controls (NC), which is then 
validated in the MC sample. In sub-analyses, we investigate the differences in 
diagnostic accuracy in relation to demographic adjustments by comparing the 
original MoCA score with recently established demographically corrected MoCA z-
scores (Thomann, Goettel, Monsch, et al., 2018). During our analyses, we noticed 
that information is lost when a continuous variable like the MoCA is dichotomized 
(M. D. Brown & Reeves, 2003; Vermeersch et al., 2009), and a traditional binary 
cut-off is used. We therefore propose a new approach to evaluate cognitive 
performance on the MoCA using two separate cut-offs in combination with a gray 
area between these scores. 
 
4.2 METHODS 
4.2.1 Participants 
We retrospectively assessed data from 1,307 consecutive outpatients of the 
Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER, 
Basel, Switzerland, undergoing neuropsychological assessment between March 6, 
2017 and October 12, 2018. Data from patients meeting the following inclusion 
criteria were considered for the analysis: (1) age ≥65 years, (2) education ≥7 years, 
(3) fluency in the German language, and (4) availability of a neuropsychological 
assessment including the Mini Mental Status Examination (MMSE; Folstein et al., 
1975) and the MoCA. Exclusion criteria were: (1) severe sensory or motor 
impairment interfering with cognitive testing, (2) repeated testing with the MoCA 
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due to follow-up examinations, and (3) documented refusal of the use of personal 
health-related data for research purposes. An overview of the clinical diagnoses is 
provided in Supplementary Table 1. The demographic inclusion criteria were 
selected to match the NC group from a previous normative study on the MoCA (see 
Thomann, Goettel, Monsch, et al., 2018 for details). 
 
4.2.2 Procedures 
Patients were assessed in the following order: (1) detailed patient and medical 
history, (2) neuropsychological screening including the MMSE and the clock 
drawing test, (3) MoCA, (4) assessment of symptoms of depression, and (5) 
extensive neuropsychological examination. Neuropsychological assessments were 
performed by board-certified neuropsychologists and by psychologists with a 
Master’s degree. Neuropsychological test results were interpreted based on 
demographically corrected (i.e., age, sex, and education) z-scores. The patients 
were medically examined by a neurologist or a geriatrician. Imaging (i.e., structural 
magnetic resonance imaging, computed tomography and/or positron emission 
tomography with 18F-fluorodeoxyglucose) was performed and in some patients, 
cerebrospinal fluid was collected to assess for protein deposition. Diagnostic 
consensus was reached in weekly interdisciplinary meetings by 
neuropsychologists, neurologists, neuroradiologists, positron emission tomography 
specialists, geriatricians, psychiatrists, and a neuropathologist. MoCA results were 
not considered in the diagnostic process. Procedures for the NC group are 
described elsewhere (Thomann, Goettel, Monsch, et al., 2018). 
The study protocol (N° EKNZ 2018-00737) was approved by the regional research 
ethics board (Ethikkommission Nordwest- und Zentralschweiz [EKNZ]) on May 22, 
2018. The study was conducted in respect of the most recent version of the 
Declaration of Helsinki and was registered on ClinicalTrials.gov (NCT03581643). 
The need for informed consent was waived by the EKNZ. 
 
4.2.3 Statistical analyses 
Demographical characteristics and test scores were compared pairwise using the 
non-parametric Wilcoxon rank sum test for between-group comparisons. 
Differences in sex were analyzed using the chi-squared test. 
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Diagnostic accuracies of the original MoCA cut-off (25/26 points) were calculated 
in the MC sample. Using the Optimal Cutpoints Package in R (López-Ratón, 
Rodríguez-Álvarez, Cadarso-Suárez, & Gude-Sampedro, 2014), the Youden’s 
index (Sensitivity+Specificity-1; Youden, 1950), was applied to define the optimal 
cut-offs in the MC sample for the MoCA score, the MoCA z-score, and the MMSE. 
Additionally, MoCA cut-offs were derived based on the NC group. Specificity was 
held at approximately 90% in the NC group by choosing the scores that split the 
sample at the 10th percentile. Hence, normality is defined as a reference range 
based on the distribution of scores in cognitively healthy individuals, and scores 
below the 10th percentile were considered pathological. The resulting cut-offs were 
then validated in the MC sample to differentiate Mild+Major NCD vs. NF and Mild 
NCD vs. NF.  
The discriminative power of the MoCA score, the MoCA z-score, and the MMSE 
score was estimated in terms of area under the curve (AUC) in the MC sample. 
Receiver Operating Characteristic (ROC) curves were calculated using the pROC 
package in R (Robin et al., 2011). The AUCs of the MoCA score vs. MoCA z-score, 
the MoCA score vs. MMSE score, and the MoCA z-score vs. MMSE score were 
compared with a bootstrap two-sided significance test for correlated ROC curves. 
The correct classification rates of the newly derived MoCA cut-offs were compared 
to the original MoCA cut-off and the optimal cut-offs on the MMSE using the 
McNemar’s test. Results were corrected for multiple comparisons according to 
Bonferroni-Holm.  
We created a plot to visualize the relationship between MoCA scores and rates of 
sensitivity and specificity. For this purpose, cumulative frequencies were calculated 
separately for Mild NCD and for NC for each MoCA score. Thus, the proportion of 
individuals who performed equally or below a given score was determined for each 
score and expressed in percent of the whole sample. The cumulative frequency for 
a given score in Mild NCD corresponds to the sensitivity. Specificity is represented 
by the complementary sum (1 - cumulative frequency) in NC. 
All statistical analyses were performed using R, version 3.5.0 (R Foundation, 
Vienna, Austria) and RStudio Desktop (RStudio, Boston, MA, USA). Data are 
presented as mean (SD), and the education-corrected MoCA score (+1 point for 
<12 years of education) was used, unless stated otherwise. There were no missing 
data in any of the analyses. 
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4.3 RESULTS 
4.3.1 Descriptive analysis 
Four hundred and forty-seven patients (Mild+Major NCD), 49 normal findings (NF), 
and 283 normal controls (NC) were included in the final analysis. Demographic 
characteristics are displayed in Table 1. There were no differences between NC 
and NF. Compared to NF, the patients (i.e., Mild+Major NCD, Mild NCD) were older 
(P value < .001), had fewer years of formal education (P value < .001), and lower 
test scores (MMSE: P value < .001; MoCA: P value < .001, MoCA z-score: P value 
< .001). There were no sex differences between the groups. 
 
Table 1. Demographic characteristics. 
 
Data are presented as mean (SD). Mild MCD is a subgroup of Mild+Major NCD. 
MMSE = Mini Mental-State Examination; MoCA = Montreal Cognitive 
Assessment; z-score = demographically corrected standard score based on the 
formula by Thomann, Goettel, Monsch et al. (2018). There were no differences 
between NC and NF. NF is compared to Mild+Major NCD and Mild NCD: * P 
value < .001. 
 
4.3.2 Diagnostic accuracies 
ROC-curves for the MC sample are displayed in Fig. 1. The AUC of the MoCA 
scores appear larger than that of the MMSE. However, with application of the 
Bonferroni-Holm procedure, the AUC neither differed significantly between MoCA 
and MMSE scores (MoCA [AUC=0.94] vs. MMSE [AUC =0.84]: P value = .051; 
MoCA z-score [AUC = 0.94] vs. MMSE: P value = .074) nor between the 
uncorrected MoCA and the MoCA z-score (P value = 1.0).  
 
 
Table 1. Demographic characteristics. 
 
Group n Prevalence 
in MC 
sample 
% 
Age 
(y) 
Age 
range 
(y) 
Education 
(y) 
Education 
range 
(y) 
Female 
% 
MMSE 
score 
MoCA 
score 
 
MoCA 
score 
range 
 
MoCA 
z-
score 
MoCA 
z-score 
range 
NC 283 - 73.8 
(5.2) 
65-91 13.6 (2.9) 7-20 54.8 29.2 
(0.9) 
26.5 
(2.4) 
16-30 0.0 
(1.0) 
-3.0-2.4 
NF 49 9.9 73.1 
(5.6) 
65-88 13.8 (2.7) 8-20 40.8 29.0 
(1.0) 
26.5 
(2.2) 
22-30 0.1 
(1.0) 
-1.7-1.9 
Mild+Major 
NCD 
447 90.1 78.3 
(5.9) * 
65-91 12.2 (3.0) 
* 
7-20 55.7 25.1 
(3.5) * 
19.1 
(4.5) * 
2-30 -2.1 
(1.0) * 
-4.3-1.5 
Mild NCD 159 32.1 76.0 
(6.0) * 
65-91 12.4 (3.1) 
* 
7-20 53.5 27.2 
(2.2) * 
22.0 
(3.6) * 
12-30 -1.5 
(1.0) * 
-3.7-1.5 
 
Data are presented as mean (SD). Mild MCD is a subgroup of Mild+Major NCD. 
MMSE = Mini Mental-State Examination; MoCA = Montreal Cognitive Assessment; z-score = demographically corrected standard score based on 
the formula by Thomann et al., 2018. There were no differences between NC and NF. NF is compared to Mild+Major NCD and Mild NCD: * P value 
< .001. 
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Figure 1. ROC-Curves. 
 
ROC curves for the MoCA (z-score: solid line, corrected score: dashed line) and 
the MMSE (dotted line) for the classification of Mild+Major NCD (Fig. 1a) and Mild 
NCD (Fig. 1b). 
 
Cut-offs and the corresponding diagnostic properties for the MoCA and the MMSE 
are provided in Table 2. Diagnostic accuracies for the MoCA z-score are illustrated 
in Supplementary Table 2. A MoCA score of 23/24 points was the optimal cut-off 
according to the 10th percentile-method as well as according to the Youden’s index 
in all patient groups. This cut-off had better correct classification rates than the 
original MoCA cut-off (25/26 points; P value < .001) and the MMSE score (P value 
< .001) in both patient samples. Specificity for the cut-off of 23/24 points was high 
with 92%, and it had good sensitivity for Mild+Major NCD (84%). However, 
sensitivity was low for Mild NCD (65%). The original MoCA cut-off (25/26 points) 
had high sensitivity for Mild+Major NCD (94%) and for Mild NCD (86%), but poor 
specificity (63%). For Mild NCD, an intermediate cut-off (24/25 points) had neither 
good sensitivity (74%) nor good specificity (74%). We, therefore, aimed at obviating 
this trade-off between sensitivity and specificity by defining two separate cut-offs. 
This is illustrated by the example of Mild NCD vs. NC in section 3.3. 
 
 
Fig. 1a Fig. 1b 
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Table 2. Empirically derived cut-offs and diagnostic accuracy estimates for the 
MoCA and the MMSE. 
 
*Correct classification rate = (Sensitivity + Specificity)/2 
†Youden’s index = Sensitivity + Specificity - 1 
 
4.3.3 Two separate cut-offs and a gray area 
In Fig. 2, sensitivity based on Mild NCD is plotted against specificity based on NC. 
Specificity increases with lower scores, while sensitivity increases with higher 
scores. At 23/24 points, specificity is 88%, indicating that only 12% of the NC 
scored ≤23 points. At 26/27 points, sensitivity is 91%, so only 9% of patients with 
Mild NCD achieved scores >26 points. Consequently, cognitive health and 
cognitive impairment may be defined using two separate cut-offs.  
 
Table 2. Empirically derived cut-offs a  diagnostic a curacy estimat  for the MoCA and the 
MMSE. 
Measure Mild+Major NCD vs. NF Mild NCD vs. NF 
MoCA   
AUC (95% CI, DeLong) 0.94 (0.91-0.96) 0.86 (0.81-0.91) 
Original cut-off 25/26 25/26 
 Correct classification rate* 79% 75% 
 Sensitivity (95% CI) 94% (94-95%) 86% (84-87%) 
 Specificity (95% CI) 63% (60-67%) 63% (60-67%) 
Balanced cut-off 24/25 24/25 
 Correct classification rate* 82% 74% 
 Sensitivity (95% CI) 90% (89-90%) 74% (72-76%) 
 Specificity (95% CI) 74% (70-77%) 74% (70-76%) 
Cut-off; Youden’s index† 23/24 23/24 
Cut-off; 10th percentile in 
NCs 
23/24 23/24 
 Correct classification rate* 88% 79% 
 Sensitivity (95% CI) 84% (83-85%) 65% (63-67%) 
 Specificity (95% CI) 92% (90-94%) 92% (90-94%) 
MMSE  
AUC (95% CI, DeLong) 0.89 (0.85-0.93) 0.78 (0.72-0.85) 
Cutoff; Youden’s index† 27/28 28/29 
 Correct classification rate* 82% 73% 
 Sensitivity (95% CI) 72% (71-73%) 69% (67-70%) 
 Specificity (95% CI) 92% (90-94%) 76% (72-79%) 
Abbreviations: AUC = Area under the curve; CI = Confidence interval; NC = Normal Controls; 
NCD = Neurocognitive disorder; NF = Normal Findings. 
*Correct classification rate = ( ensitivity + Specificity)/2 
†Youden’s index = Sensitivity + Specificity - 1 
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Figure 2. Two separate cut-offs and a gray area. 
 
The percentage of patients with Mild NCD who were correctly classified as 
patients (sensitivity, red line) and the percentage of normal controls that were 
correctly classified as normal controls (specificity, green line) are illustrated. Two 
cut-offs are illustrated by the dashed lines, one cut-off for not-healthy results 
(23/24; with 88% specificity) and one cut-off for not-pathological results (26/27; 
with 91% sensitivity). Scores between these two cut-offs constitute a gray area, 
where information from further examinations is required. 
 
Analogous to the concept of z-scores, a distribution of scores is assumed, and 
extreme values are considered improbable for a specific population. For cognitive 
health, values below a given cut-off (i.e., 23 points) are rare, suggesting that an 
individual scoring ≤23 points is probably not healthy. This statement was accurate 
in 88% of the NC group (= specificity). Values above a given cut-off (i.e., >26 points) 
are uncommon in Mild NCD. Therefore, an individual who attains >26 points on the 
MoCA probably does not suffer from an NCD. This statement was accurate in 91% 
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of Mild NCD patients (= sensitivity). Scores between these two cut-offs (24, 25, and 
26 points) constitute a gray area. This gray area may be greater or smaller, 
depending on the desired accuracies (i.e., for sensitivity of 95% and specificity of 
95%, the gray area would encompass MoCA scores from 23 to 26 points). The 
corresponding positive predictive values (PPV) and negative predictive values 
(NPV) are plotted in Supplementary Fig. 1. 
 
4.4 DISCUSSION 
The German MoCA showed good AUC, sensitivity, and specificity for the 
classification of patients with mild and major NCD versus cognitively healthy normal 
findings when applied in a heterogeneous group of individuals referred to a 
university-affiliated Memory Clinic. In the present study, a MoCA score of 23/24 
points was established as the optimal cut-off across different patient groups based 
on two methods. This finding is in line with a recent meta-analysis including seven 
validation studies on the MoCA (Carson et al., 2018). The new MoCA cut-off had 
an improved correct classification rate compared to both, the original MoCA cut-off 
and the MMSE. Further, differences in diagnostic accuracy depending on the 
severity of cognitive impairment (Mild vs. Major NCD) were revealed. While a cut-
off of 23/24 points had high sensitivity for all patients (Mild+Major NCD [84%]), 
sensitivity was low for Mild NCD (65%). When applying a higher cut-off (e.g., the 
originally proposed 25/26 points), sensitivity for Mild NCD increased to 91%; 
however, specificity to detect NF was low (59%). If both measures are balanced, 
neither of them is sufficiently high. Indeed, most screening tools for MCI lack either 
sensitivity or specificity (Summers & Bondi, 2017). Since there are currently no 
effective treatments for most of the underlying causes of MCI, there is no reason 
to favor one over the other. Based on the findings of this study, we propose a new 
method to evaluate cognitive performance, taking the MoCA as an example. 
Instead of applying a single cut-off, two separate cut-offs may be used. One cut-off 
for results that are unlikely within the normal range, and one cut-off for scores that 
are rarely seen in patients. MoCA scores >26 points may be considered as not 
pathological with very high accuracy, while scores ≤23 points are very likely not 
healthy. Between these scores, we have defined a gray area. When some individual 
scores within this gray area, the clinician should gather more information to guide 
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decision-making or perform a follow-up testing in approximately six to twelve 
months. 
 
4.4.1 Choice of normative samples and patient characteristics 
It has been argued that a restrictive cognitively healthy normative group may not 
be entirely comparable to the population, who is typically screened with the MoCA. 
This may artificially boost specificity of a test and lead to an overestimation in 
diagnostic accuracy (Martin et al., 2017; Noel-Storr et al., 2014). We addressed 
this issue by analyzing two groups of cognitively healthy individuals: one that was 
purposely recruited for a previous normative study (NC), and one that was formed 
by consecutively referred patients with a cognitive normal finding (NF). In our study, 
there were no differences between the NC and the NF group, neither in 
demographic characteristics nor in cognitive performance. Furthermore, the 
optimal MoCA cut-offs were identical in these two groups. This suggests that the 
healthy controls in our study are representative for individuals with cognitive normal 
findings in the clinical routine. While this is reassuring, longitudinal data from 
individuals, who remained healthy for several years, should be analyzed in future 
studies. 
 
4.4.2 Influence of demographic adjustments on diagnostic accuracy 
The utility of demographical adjustments has been questioned in previous reports 
(Strauss et al., 2006), since age and education are per se risk factors of cognitive 
decline. Indeed, patients with mild or major NCD in our study were older and had 
less years of formal education when compared to the NF group. On the other hand, 
some authors (including our group) have suggested that correcting for 
demographical effects may increase diagnostic accuracy when evaluating cognitive 
performance (Carson et al., 2018; Thomann, Goettel, Monsch, et al., 2018). 
Conversely, we found no difference between demographically corrected and 
uncorrected MoCA scores in the overall diagnostic accuracy measured by the AUC. 
However, a difference emerged in the balance of sensitivity and specificity. When 
considering the effects of age, education, and sex (z-scores), the MoCA gained 
specificity, while the uncorrected MoCA score showed increased sensitivity. The 
education-corrected MoCA score was located in between, with higher sensitivity 
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but lower specificity compared to the MoCA z-score, and lower sensitivity but higher 
specificity compared to the uncorrected MoCA score. This result is in line with 
previous findings from a simulation (O'Connell & Tuokko, 2010). Whether to rely on 
a demographically adjusted score or on an uncorrected raw score may depend on 
the setting. For instance, when the MoCA is applied to identify cognitively healthy 
participants in clinical research, high sensitivity might be more important to avoid 
the inclusion of patients with false-negative test results. In contrast, high specificity 
should be favored over sensitivity to avoid including healthy individuals with false-
positive results if cognitively impaired patients are included in a clinical trial. Indeed, 
the erroneous inclusion of cognitively healthy individuals as patients may mask 
possible treatment effects in clinical trials (Edmonds et al., 2018). When a general 
practitioner should decide whether to refer a patient to a specialized Memory Clinic 
based on cognitive screening, false-positive results should be minimized to reduce 
discomfort for the individual and healthcare costs. On the other hand, false-
negative results may deprive a patient of the early implementation of therapeutic 
strategies. In this situation, we suggest relying on our new system with two separate 
cut-offs and a gray zone.  
 
4.4.3 Limitations 
Sensitivity, specificity, and the AUC give an indication of the quality of the test under 
observation by classifying the test performance with respect to a reference 
standard (i.e., an individual will be classified as a patient on the MoCA as well as 
according to a complete Memory Clinic diagnostic workup). However, these 
measures do not inform about the probability whether a tested individual has a 
specific disease (Trevethan, 2017; Weissberger et al., 2017). Predictive values, 
which are influenced by prevalence rates, reflect this information. In the current 
study, the MoCA had very high PPV across all patient groups and most MoCA 
scores (see Supplementary Fig. 1). However, the PPV will be lower in a setting with 
a low prevalence of disease (e.g., when screening for cognitive impairment at the 
general practitioner’s office). Likewise, in most MoCA studies reporting PPV and 
NPV, the prevalence of MCI was greater than in the general population (Ozer et 
al., 2016). Ideally, the diagnostic accuracy of a test should be evaluated in the same 
setting where it is clinically applied (Habibzadeh, Habibzadeh, & Yadollahie, 2016). 
We did not have access to any data from first step screening processes (i.e., from 
a general practitioner’s office). Thus, our findings inform about how well the MoCA 
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classifies individuals as healthy or cognitively impaired compared to a more 
extensive, multi-dimensional, diagnostic process, as performed in our Memory 
Clinic (described in 2.2. Procedures). Additionally, we can provide the probability 
for a Memory Clinic patient to be affected by a mild or major NCD, when the MoCA 
performance is below the cut-off (PPV), as well as the probability that the patient is 
cognitively healthy, when the performance lies above the cut-off (NPV; Trevethan, 
2017). Therefore, our findings do not inform conclusively about the probability of 
having mild or major NCD in any other setting than the Memory Clinic. We refer to 
the excellent recent publication by Trevethan (2017) for a better understanding on 
the informative value of sensitivity, specificity, PPV, and NPV. 
 
4.5 CONCLUSIONS 
In the present study, the diagnostic properties of the German MoCA were evaluated 
in an outpatient sample referred to a university-affiliated Memory Clinic. The 
originally proposed MoCA cut-off (25/26 points) had good sensitivity for mild and 
major NCD, but specificity was poor. As an alternative, a cut-off of 23/24 points on 
the MoCA improved specificity. However, the sensitivity to detect mild NCD was 
low using this cut-off. Thus, both cut-offs lead to a trade-off in either sensitivity 
(23/24 points) or specificity (25/26 points). In this context, we propose a new 
method to guide clinical decision making by relying on two separate cut-offs 
combined with a gray area. Adding a gray area will increase both sensitivity and 
specificity. Moreover, the presence of a gray area highlights the difficulties related 
to the early detection of cognitive impairment and mirrors the clinical reality quite 
accurately. 
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Supplementary table 1. Diagnoses in the patient sample. 
 
Diagnoses Mild 
NCD 
Major 
NCD 
Total 
Alzheimer’s clinical syndrome [1] 55 237 292 
Vascular cognitive impairment [2, 3] 15 12 27 
Lewy Body disease [4] 1 3 4 
Behavioral variant fronto-temporal dementia 
[5] 
0 4 4 
Parkinson’s disease [6] 3 5 8 
Multiple system atrophy [7] 0 2 2 
Progressive supranuclear palsy [8] 2 0 2 
Primary progressive aphasia [9] 2 2 4 
Posterior cortical atrophy [10] 0 2 2 
Psychiatric disorder  7 1 8 
Obstructive sleep apnea 4 0 4 
Sleep disorder 3 0 3 
Uncertain 39 9 48 
Other 28 11 39 
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Supplementary table 2. Empirically derived cut-offs and diagnostic accuracy 
estimates for the MoCA z-score. 
 
The MoCA z-score is a demographically corrected standard score based on the 
formula by Thomann, Goettel, Monsch et al. (2018). 
Abbreviations: AUC = Area under the curve; CI = Confidence interval; NC = 
Normal Controls; NCD = Neurocognitive disorder; NF = Normal Findings. 
* Youden’s index = Sensitivity + Specificity - 1 
†Correct classification rate = (Sensitivity + Specificity)/2 
 
 
Supplementary table 2. Empirically derived cut-offs and diagnostic accuracy estimates for the 
MoCA z-score. 
Measure Mild+Major NCD vs. NF Mild NCD vs. NF 
AUC (95% CI, DeLong) 0.94 (0.91-0.96) 0.86 (0.81-0.91) 
Cut-off; Youden’s index* ≤-1.3 ≤-1.1 
 Correct classification rate† 88% 79% 
 Sensitivity (95% CI) 81% (80-82%) 68% (66-70%) 
 Specificity (95% CI) 94% (92-96%) 90% (88-92%) 
Cut-off; 10th percentile in NCs ≤-1.4 ≤-1.4 
 Correct classification rate† 88% 79% 
 Sensitivity (95% CI) 80% (79-81%) 61% (59-63%) 
 Specificity (95% CI) 96% (95-97%) 96% (95-97%) 
 
NOTE. The MoCA z-score is a demographically corrected standard score based on the formula 
by Thomann et al., 2018. 
Abbreviations: AUC = Area under the curve; CI = Confidence interval; NC = Normal Controls; 
NCD = Neurocognitive disorder; NF = Normal Findings. 
* Youden’s index = Sensitivity + Specificity - 1 
†Correct classification rate = (Sensitivity + Specificity)/2 
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Supplementary Figure 1. Positive and negative predictive values. 
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In Supplementary Fig. 1a, the positive predictive values (PPV) and negative 
predictive values (NPV) are plotted for Mild NCD vs. NF and highlighted for the 
proposed cut-offs of 23/24 points and 26/27 points. In Supplementary Fig. 1b, 
PPV and NPV are illustrated for Mild+Major NCD vs. NF. In all patient groups, 
PPV decrease and NPV increase with higher MoCA threshold scores. Again, 
using two separate cut-offs enhances both, PPV and NPV. 
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ABSTRACT 
Background: Pre-existing cognitive impairment in surgical patients is one of the 
leading risk factors for adverse cognitive outcomes such as postoperative delirium 
and postoperative cognitive dysfunction. We developed a self-administered tablet 
computer application intended to assess the individual risk for adverse 
postoperative cognitive outcomes. This cross-sectional study aimed to establish 
normative data for the tool. 
Methods: Healthy volunteers aged ≥ 65 years were administered the Mini-Mental 
State Examination (MMSE), Geriatric Depression Scale (GDS), and Consortium to 
Establish a Registry for Alzheimer’s Disease-Neuropsychological Assessment 
Battery (CERAD-NAB) to assess cognitive health. All subjects completed the tablet 
computer application without assistance. Primary outcome measure was the test 
performance. Regression models were built for each cognitive domain score with 
the covariates age, gender, and education in cognitively healthy subjects. 
Demographically-adjusted standard scores (z-scores) were computed for each 
subtest. 
Results: 283 participants (155 women, 128 men) were included in the final 
analysis. Participants’ age was 73.8 ± 5.2 years (mean ± SD) and their level of 
education was 13.6 ± 2.9 years. MMSE score was 29.2 ± 0.9 points, GDS score 
was 0.4 ± 0.7 points, and CERAD-NAB total score was 98.7 ± 5.7 points. Older age 
was associated with poorer performance in the visual recognition task and in Trail 
Making Test B (P < 0.05 after Bonferroni-Holm adjustments).  
Conclusions: This study provides normative data for a novel self-administered 
tablet computer application that is ultimately designed to measure the individual 
risk for adverse postoperative cognitive outcomes in elderly patients. 
 
Trial Registration: ClinicalTrials.gov NCT02708823 
 
Keywords: cognitive function; assessment; postoperative delirium; postoperative 
cognitive dysfunction; tablet computer application; normative data  
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5.1 INTRODUCTION 
In light of a growing geriatric patient population, health care professionals are 
increasingly faced with specific challenges of elderly patients in the primary care 
and hospital setting. The need for surgical procedures increases with patient age 
(Hall et al., 2010). Elderly patients undergoing surgery are more vulnerable to 
adverse postoperative outcomes due to advanced age, frai lty, and concomitant 
medical conditions (Story et al., 2010). Adverse cognitive outcomes such as 
postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) are 
frequently encountered in older surgical patients and are associated with increased 
morbidity and mortality (Sanders et al., 2011; Steinmetz et al., 2009; Witlox et al., 
2010). An early identification of risk factors is useful for the targeted prevention of 
cognitive disorders in hospitalized patients (Inouye et al., 1999). While most 
predictors for POD and POCD may be detected in the medical history, clinical 
examination, or laboratory investigations, some may be missed in the absence of 
a specific assessment. Pre-existing cognitive impairment in surgical patients is one 
of the strongest risk factors for further postoperative cognitive decline including 
POD (Dasgupta & Dumbrell, 2006; Inouye et al., 2014; Jones et al., 2006; Sprung 
et al., 2017) and POCD (Nadelson et al., 2014; Silbert et al., 2015). However, it 
tends to be underdiagnosed (Prince, Bryce, & Ferri, 2011; Young, Meagher, & 
Maclullich, 2011), because an objective evaluation of the cognitive performance is 
time-consuming and usually requires trained personnel. Therefore, it may be 
challenging to implement the routine assessment of cognitive status in all geriatric 
patients presenting for surgery (C. Brown & Deiner, 2016). Besides, most cognitive 
screening tools available to date are not specifically intended for preoperative use 
in surgical patients (Long, Shapiro, & Leung, 2012). Some current risk prediction 
models for POD do not include the assessment of cognitive functions at baseline 
(Evered, 2017; Lee et al., 2017). 
Our goal was to create a new tool to assess individual baseline cognition as a major 
risk factor for adverse postoperative cognitive outcomes in surgical patients. Key 
requirements for the design of the CogCheck application were self-administration, 
user-friendliness, language-free content (pictures), conciseness (i.e., 
administration time < 30 minutes), and automated scoring. These may facilitate 
routine use in clinical practice (e.g., during preoperative evaluation for anesthesia) 
and offer potential advantages over other screening tools. Eventually, the purpose 
of the CogCheck application is to simplify and standardize preoperative cognitive 
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testing in the elderly. Compared to CogCheck, other preoperative cognitive 
assessments do not use computerized testing (Long et al., 2012), which may be 
beneficial regarding test reliability and scoring. In addition, the self-administrative 
character of CogCheck and the possibility of remote and parallel testing may 
reduce personnel and resource costs. 
The development of such tool involves several steps: (1) identification of relevant 
cognitive domains, (2) choice of task to assess these domains, (3) computer 
programming of the tasks, (4) pilot study to assess applicability of the tool, and (5) 
collection of normative data in a group of individuals with established cognitive 
health (Crook, Kay, & Larrabee, 2009). Once these steps have been carried-out 
successfully, the new tool may be used in a series of validation studies. The 
objective of this cross-sectional study was to collect normative data in cognitively 
healthy individuals, and find the adjustment necessary to eliminate the influence of 
demographic characteristics (age, gender, and education).  
 
5.2 MATERIALS AND METHODS 
5.2.1 Study design 
We conducted a cross-sectional study to acquire normative data for the tablet 
computer-based application, CogCheck. Ethical approval for this study (protocol N° 
EKNZ BASEC 2016-00393) was provided by the institutional ethics board 
(Ethikkommission Nordwest- und Zentralschweiz) on April 12, 2016. A substantial 
amendment to the study protocol was approved on November 11, 2016. All study 
participants provided written informed consent. The study was conducted in respect 
of the most recent version of the Declaration of Helsinki and registered on 
ClinicalTrials.gov (NCT02708823) prior to data acquisition. This manuscript 
adheres to the applicable EQUATOR network guidelines. 
 
5.2.2 Participants and setting 
All study participants were healthy nonsurgical volunteers recruited from the 
Registry of Individuals Interested to Participate in Research established by the 
Memory Clinic, University Center for Medicine of Aging Basel, Felix Platter 
Hospital, in Basel, Switzerland. Only subjects who had previously filled out a 
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standardized medical questionnaire were considered. Data from eligible 
participants were screened for inclusion and exclusion criteria. Inclusion criteria 
were: (1) age ≥ 65 years, (2) education ≥ 7 years, (3) fluency in the German 
language, and (4) written informed consent. Exclusion criteria were: (1) history of 
cognitive impairment, (2) signs of depression, (3) severe sensory or motor 
impairment interfering with cognitive testing, (4) serious somatic disease, disease 
or event affecting the central nervous system (head trauma with loss of 
consciousness > 5 minutes, any brain surgery, general anesthesia within the last 3 
months, alcoholism, intoxication with neurotoxic substances), (5) cerebrovascular 
disease, (6) regular medication with psychoactive drugs except for 
benzodiazepines, and (7) participation in any cognitive study within the last 3 
months or previous participation in a study using CogCheck. 
In order to ensure cognitive health of participants, only those with at least 27/30 
points (Thalmann et al., 2002) in the Mini-Mental State Examination (MMSE; 
Folstein et al., 1975) and more than 85.89 points (Ehrensperger et al., 2010) in the 
German version of the Consortium to Establish a Registry for Alzheimer’s Disease-
Neuropsychological Assessment Battery (CERAD-NAB; Morris et al., 1989) were 
included. Subjects with more than 5/15 points on the brief version of the Geriatric 
Depression Scale (GDS; Pocklington, Gilbody, Manea, & McMillan, 2016), 
indicating signs of depression, were excluded. Optimal homogeneity of the study 
population was achieved by stratification of participants according to age and 
gender categories. 
 
5.2.3 Design of CogCheck 
The CogCheck application was developed in a joint project by the Department of 
Anesthesia at University Hospital Basel and the Memory Clinic at Felix Platter 
Hospital in Basel, Switzerland. Since objective assessment of a patient’s  cognitive 
status is highly resource-dependent (Saxton et al., 2009), our goal was to create a 
computerized risk-stratification tool for adverse postoperative cognitive outcomes 
in surgical patients that is easy to use and does not require trained personnel. 
Previous investigations showed that even persons without computer experience 
were able to perform well using computer-based tests (Fazeli, Ross, Vance, & Ball, 
2013). Moreover, study subjects were more successful when using a tablet 
computer with touch screen instead of a computer with a mouse or a keyboard 
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(Saxton et al., 2009; Werner, Werner, & Oberzaucher, 2012). Thus, we designed a 
tablet computer application in which all subtests are language-free. Instructions – 
which can be easily translated into other languages – are provided in writing and 
are complemented with short videos. This also allows for the assessment of 
patients with hearing impairment. 
We compared existing preoperative risk scores (Freter et al., 2005; S. K. Inouye, 
Viscoli, Horwitz, Hurst, & Tinetti, 1993; Marcantonio et al., 1994) to decide which 
predictors should be included in our new tool. The final version of CogCheck (see 
Figure, Supplemental Digital Content 1, which shows translated screenshots of the 
application) used for test standardization included: (1) demographic and medical 
data (sensory impairment [Kalisvaart et al., 2006), age [National Clinical Guideline 
(NGC), 2010; Wimo et al., 2017], medications [Goldenberg et al., 2006], education 
[Jones et al., 2006]), (2) cognitive self-assessment (NGC, 2010), (3) temporal 
orientation (Folstein et al., 1975; Long et al., 2012), and (4) a set of 7 automated 
subtests of cognitive functions (visual recognition [Benton, 1972], picture learning 
and recognition [Saxton et al., 2009], digit span [Erlanger et al., 2002], spatial span 
[Brunetti, Del Gatto, & Delogu, 2014], reaction time and attention [Saxton et al., 
2009], and Trail Making Tests [TMT] A and B [Salthouse & Fristoe, 1995]). The 
automated scoring system for CogCheck is based on the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5, 2013) definitions for neurocognitive disorders. 
At an initial stage, user-friendliness of CogCheck was evaluated in a pilot project 
(Burckhardt, 2014) with 20 cognitively healthy volunteers (10 women, 10 men; 
mean age: 71.8 ± 3.4 years; mean Montreal Cognitive Assessment [MoCA; 
Nasreddine et al., 2005] score: 28.0 ± 0.9 points) and 13 cognitively impaired 
patients (5 women, 8 men; mean age: 76.5 ± 4.5 years; mean MoCA score: 22.3 ± 
2.6 points) of the Memory Clinic. Twenty-seven pilot study participants (82%) 
privately owned and used a computer, 7 (21%) a tablet computer, and 9 (27%) a 
smartphone. The majority of cognitively healthy and impaired subjects were able to 
successfully complete the assessment without or with minimal help (95% and 85%, 
respectively). The CogCheck application received high overall quality and 
acceptance ratings (clear layout: 97%; easy navigation: 88%). Successively, some 
practical features of the application were improved (e.g., font size, color coding, 
and touchscreen sensibility). 
A second pilot study (Anyiam, 2018) examined CogCheck in older surgical patients 
and evaluated the applicability of the tool in a real-life clinical setting. Forty-six 
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patients (29 women, 17 men; mean age: 73.3 ± 5.6 years; mean MMSE score: 28.3 
± 1.2 points) scheduled for major surgery completed the CogCheck application in 
our anesthesia preoperative evaluation clinic. All patients were able to complete 
testing without assistance. During the first five days after surgery, patients were 
assessed for POD using the Delirium Rating Scale-Revised-98 (DRS-R-98; 
Trzepacz et al., 2001). When applying the formal DRS-R-98 cut-off scores, no 
patient was found to be affected by POD in this cohort (mean maximum DRS-R-98 
score: 5.4 ± 2.9 points; range: 0–12 points). This was possibly due to sampling 
bias. Consequently, this data set was insufficient to validate CogCheck in surgical 
patients. 
 
5.2.4 Variables and data sources 
Study participants were examined by one of four individually trained psychology 
master’s students in a quiet room, seated at a table. After obtaining consent, the 
examiner first updated the individual’s medical questionnaire and medication list. 
Second, the MMSE and GDS were administered. Subjects then performed 
CogCheck on an iPad Air tablet computer with 9.7-inch display using iOS 10.2 or 
10.3 (Apple Inc., Cupertino, CA, USA). Although the examiner remained in the room 
during CogCheck testing, he or she was not allowed to interact in any way with the 
subject. Finally, the extended German version of the CERAD-NAB (Schmid, 
Ehrensperger, Berres, Beck, & Monsch, 2014) was administered. 
Data from CogCheck were sent in real-time to a secure server at University Hospital 
Basel using a locked Wireless Local Area Network (WLAN) connection. Examiners 
were blinded to application data. Paper-based study data were recorded directly 
onto the case report form and later transferred into an electronic database using 
FileMaker Pro (FileMaker Inc., Santa Clara, CA, USA). 
 
5.2.5 Statistical analysis 
We evaluated the effects of common demographic characteristics on test 
performance and examined the distribution of scores. First, 20 regression models 
for each cognitive subtest (see Table, Supplemental Digital Content 2, which 
displays the content and structure of the CogCheck  application) were calculated 
with the covariates age, gender, education, their interactions, and their potential 
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nonlinear relationships using quadratic terms (Berres et al., 2008). The optimal 
model was determined by leave-one-out cross-validation, i.e., minimizing the 
Prediction Residual Sums of Squares (PRESS) statistics among the 20 regression 
models for each response variable (Berres et al., 2008). Second, if necessary, 
optimal transformations (Box-Cox family or arcsine) were applied to achieve 
normality and homoscedasticity of the residuals. Third, step one was repeated with 
transformed variables determining an optimal model from the 20 models. This was 
always the same or a similar model as in step one, which speaks for a certain 
robustness of the analysis. Finally, formulae for demographically-adjusted standard 
scores (z-scores) were computed based on the final regression model. The 
Bonferroni-Holm method for multiple testing was applied in order to estimate the 
hypothetical effects of age and education in all subtests. 
In order to estimate the 5th and 95th percentile with a maximum deviation of 2% for 
the normative data (Jennen‐Steinmetz & Wellek, 2005), at least 171 subjects were 
needed. Age, gender, and education were predefined as predictor variables, and 
three additional predictor variables with interactions and quadratic terms were 
anticipated. Ten subjects per predictor variable were included to account for 
adjustments in the regression models. Hence, the minimum sample size was 231. 
All statistical analyses were performed using R, version 3.4.1 (R Foundation, 
Vienna, Austria). 
 
5.3 RESULTS 
5.3.1 Participants 
All study-related examinations took place between December 2016 and April 2017. 
At the time of the study, the Registry of Individuals Interested to Participate in 
Research counted 2162 volunteers, including 794 subjects who had filled out a 
standardized medical questionnaire. Of 487 eligible subjects who were contacted 
by letter, 334 were included in the study. The final sample for analysis consisted of 
283 cognitively healthy volunteers (155 women, 128 men). Figure 1 shows the 
process of recruitment and inclusion in detail. For the final sample (n = 283), mean 
subject age was 73.8 ± 5.2 (range 65–91) years, and mean education was 13.6 ± 
2.9 (range 7–20) years. Each age category was represented by at least 21 subjects 
per gender. The study population comprised nearly equal numbers of men and 
  
 71 
women in each age category. Demographic characteristics, medical comorbidities, 
and neuropsychological test results of participants are summarized in Table 1. 
There was no missing data on the key variables in our main analysis. 
 
Table 1. Demographic characteristics according to age category 
 
Data are presented as mean (SD), unless otherwise stated. CERAD-NAB = 
Consortium to Establish a Registry for Alzheimer’s Disease-Neuropsychological 
Assessment Battery; GDS = Geriatric Depression Scale; MMSE = Mini-Mental 
State Examination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 1. Demographic characteristics according to age category 
 
 
All 
participants 
(n = 283) 
65–69 years 
(n = 68) 
70–74 years 
(n = 102) 
75–79 years 
(n = 68) 
> 79 years 
(n = 45) 
Age; years 73.8 (5.2) 67.6 (1.4) 72.2 (1.3) 76.5 (1.4) 82.6 (2.4) 
Male gender; n (%) 128 (45.2) 26 (38.2) 44 (43.1) 34 (50.0) 24 (53.3) 
Education; years 13.6 (2.9) 13.2 (2.7) 14.0 (2.8) 13.7 (3.1) 13.3 (2.8) 
MMSE score; points 29.2 (0.9) 29.4 (0.7) 29.3 (0.9) 29.0 (0.9) 28.9 (1.0) 
GDS score; points 0.4 (0.7) 0.3 (0.8) 0.4 (0.7) 0.3 (0.6) 0.4 (0.7) 
CERAD-NAB-Plus total score; 
points 
98.7 (5.7) 97.9 (5.5) 98.6 (5.2) 99.5 (5.9) 99.0 (6.5) 
 
Data are presented as mean (SD), unless otherwise stated. 
CERAD-NAB = Consortium to Establish a Regi try for Alzheimer’s Disease-Neuropsychological 
Assessment Battery; GDS = Geriatric Depression Scale; MMSE = Mini-Mental State Examination. 
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Fig. 1. Recruitment process.  
 
 
 
Completed medical 
questionnaire (n = 794)
Not eligible (n = 307)
• Age <65 years
• History of cognitive impairment
• Known diagnosis meeting an exclusion criteria
Eligibility screening
(n = 487)
Excluded (n = 153)
• Signs of depression (n =  4)
• Severe sensory or motor impairment (n = 9)
• Serious somatic disease (n = 10)
• Disease or event affecting the central nervous 
system (n = 28) 
• Cerebrovascular disease (n = 14)
• Regular intake of psychoactive drugs (n = 4)
• Participation in any cognitive study within the 
last 3 months or previous participation in a study 
using the application (n = 12)
• Could not be contacted or deceased (n = 16)
• Declined to participate (n = 56)
Included 
(n = 334)
Drop-out (n = 51)
• No fluency in German language (n = 4)
• Education <7 years (n = 1)
• Cognitive impairment in MMSE and/or CERAD-
NAB (n = 39)
• Severe sensory or motor impairment (n = 2)
• Disease or event affecting the central nervous 
system (n = 2)
• Withdrew consent (n = 1)
• Not specified (n = 2) 
Analyzed 
(n = 283)
Registry of volunteers             
(n = 2162)
  
 73 
Table 2. CogCheck test results 
 
Data are presented as mean (SD), unless stated otherwise. TMT = Trail Making 
Test. 
aError analysis showed that 97.4% of subjects, who had entered an incorrect age, 
had rounded their age up to the next year. 
bCognitive functions were self-assessed on a five-point Likert scale (1 = much 
worse, 2 = somewhat worse, 3 = no change, 4 = somewhat better, 5 = much 
better) compared to two years ago. 
cError analysis showed that 0.7% of subjects entered the weekday incorrectly, 
17.6% entered the day incorrectly, none entered the month incorrectly, and 1.1% 
entered the year incorrectly. 
dPossible range of values is 0 to 15 for visual recognition, 0 to 30 for picture 
recognition, 0 to 16 for spatial span, and 0 to 18 for digit span. 
TABLE 2. CogCheck test results 
 
 
All 
participants 
(n = 283) 
65–69 years 
(n = 68) 
70–74 years 
(n = 102) 
75–79 years 
(n = 68) 
> 79 years 
(n = 45) 
Demographic and medical data; n (%) 
Sensory impairment 
    Use of vision aids 272 (96.1) 66 (97.0) 95 (93.1) 66 (97.1) 45 (100) 
    Presence of hearing impairment 121 (42.8) 22 (32.4) 34 (33.3) 32 (47.1) 33 (73.3) 
Daily drug intake      
    No drugs 60 (21.2) 18 (26.5) 25 (24.5) 11 (16.2) 6 (13.3) 
    1 to 3 drugs 172 (60.8) 46 (67.7) 62 (60.8) 40 (58.8) 24 (53.3) 
    4 to 7 drugs 42 (14.8)  4 (5.9) 12 (11.8) 15 (22.1) 11 (24.4) 
    >7 drugs 9 (3.2) 0 (0) 3 (2.9) 2 (2.9) 4 (8.9) 
Age entered correctlya 245 (86.6) 60 (88.2) 92 (90.2) 60 (88.2) 33 (73.3) 
Education entered correctly 137 (48.4)  33 (48.5) 48 (47.1) 31 (45.6) 25 (55.6) 
Language      
1.     Native German speaker 277 (97.9) 68 (100) 100 (98.0) 66 (97.1) 43 (95.6) 
2.     Other, but fluent in German 6 (2.1) 0 (0) 2 (2.0) 2 (2.9) 2 (4.4) 
Cognitive self-assessmentb 
Memorizing new things 2.6 (0.5) 2.7 (0.5) 2.6 (0.5) 2.6 (0.6) 2.4 (0.5) 
Remembering names 2.4 (0.6) 2.5 (0.6) 2.4 (0.6) 2.4 (0.6) 2.3 (0.6) 
Multiple simultaneous tasks 2.8 (0.4) 2.9 (0.4) 2.8 (0.5) 2.7 (0.5) 2.7 (0.4) 
Financial issues 3.1 (0.3) 3.0 (0.2) 3.1 (0.4) 3.0 (0.3) 3.0 (0.4) 
Remembering appointments 3.0 (0.3) 3.0 (0.3) 3.0 (0.3) 3.0 (0.2) 2.9 (0.3) 
Temporal orientation;c n (%) 
Weekday entered correctly 281 (99.3) 68 (100) 101 (99.0) 67 (98.5) 45 (100) 
Date entered correctly 231 (81.6) 56 (82.4) 81 (79.4) 58 (85.3) 36 (80.0) 
Automated subtests of cognitive functions 
Visual recognition; raw scored 12.0 (1.9) 12.3 (1.7) 12.2 (1.7) 12.0 (1.7) 10.8 (2.3) 
Picture recognition; raw scored 27.5 (2.1) 28.1 (1.8) 27.5 (2.1) 26.7 (2.3) 27.5 (2.0) 
Spatial span; raw scored 7.0 (1.7) 7.2 (1.7) 7.1 (1.7) 7.2 (1.6) 6.2 (1.8) 
Digit span; raw scored 8.4 (2.0) 8.7 (2.1) 8.4 (2.1) 8.6 (1.9) 7.5 (1.8) 
TMT-A; number of line 
connections/min 
21.9 (5.9) 23.4 (6.1) 22.2 (6.2) 21.7 (5.6) 19.3 (3.7) 
TMT-B; number of line 
connections/min 
15.1 (4.1) 16.5 (3.3) 15.7 (3.9) 14.8 (4.2) 12.3 (3.9) 
 
Data are presented as mean (SD), unless stated otherwise. 
aError analysis showed that 97.4% of subjects, who had entered an incorrect age, had rounded their 
age up to the next year. 
bCognitive functions were self-assessed on a five-point Likert scale (1 = much worse, 2 = somewhat 
worse, 3 = no change, 4 = somewhat better, 5 = much better) compared to two years ago. 
cError analysis showed that 0.7% of subjects entered the weekday incorrectly, 17.6% entered the 
day incorrectly, none entered the month incorrectly, and 1.1% entered the year incorrectly. 
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5.3.2 Results of CogCheck  
Demographic data, self-assessment of cognitive functions and testing of temporal 
orientation originating from CogCheck are summarized in Table 2. The mean time 
necessary to complete the application was 21.7 ± 2.2 minutes. All participants were 
able to successfully complete the assessment without help. 
The influence of age, gender, and education on other subtests was not uniformly 
negative or positive due to interactions and quadratic effects. When applying the 
Bonferroni-Holm adjustment to test the effect of age and education in six subtests 
(α = 0.05), the age effect was significant in the visual recognition task and TMT-B. 
The education effect was significant in the visual recognition task and fell just short 
of significance in TMT-B (adjusted P = 0.054). Because of modifying effects 
(interactions and quadratic terms), uniform effects of age and education could not 
be tested in the other four subtests. 
 
5.3.3 Calculation of standard scores 
For each cognitive subtest of CogCheck, we chose the best predictive model and 
computed demographically-adjusted standard scores (z-scores). The basic formula 
for the calculation of standard scores (z = [transformed score – expected score]/ 
residual standard error) was applied for each cognitive subtest (Table 3). The 
Figure in Supplemental Digital Content 3 provides the detailed analysis of all 
CogCheck subtests. 
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Table 3. Formulae for demographically-adjusted standard scores 
 
The basic formula for the calculation of standard scores is z = (transformed score 
- expected score) / residual standard error. 
*No transformation was necessary to receive normal distribution for the dig it span 
score. 
A = age; E = education; G = gender; RS = raw score; TMT = Trail Making Test. 
 
5.4 DISCUSSION 
The CogCheck application is a completely self-administered cognitive assessment 
and screening tool intended for use in surgical patients. This cross-sectional study 
provides demographically-adjusted normative data for the CogCheck tool. Taking 
into account age, gender, and education, we calculated standard scores for six 
cognitive subtests that, in combination, may provide an indication of the overall  
cognitive status. Two previous pilot studies independently demonstrated the user-
friendliness and applicability of CogCheck in cognitively healthy and impaired 
subjects, as well as in surgical patients.  
Pre-existing cognitive impairment is reported to have a significant impact on the 
incidence of adverse postoperative cognitive outcomes. In earlier studies, the odds 
ratio for delirium ranged from 6.3 (95% confidence interval [CI] 2.9–13.7) up to 11.5 
(95% CI 6.1–20.1) in patients suffering from cognitive impairment (Wimo et al., 
2017). For POCD, the odds ratio was 2.4 (95% CI 1.1–5.5) (Silbert et al., 2015). 
After validation of CogCheck in surgical patients, the tool may eventually screen 
for cognitive impairment as a major risk factor for adverse postoperative cognitive 
outcomes via self-administered testing on a tablet computer. 
Participants of the current normative study were cognitively healthy volunteers, and 
relatively strict exclusion criteria (cut-off scores for MMSE, CERAD-NAB, and GDS) 
TABLE 3. Formulae for demographically-adjusted standard scores 
 
Cognitive 
subtest 
Standard score formula 
Visual recognition z = ((RS - 2)1.5 - (54.694 - 0.398 × A + 0.479 × E)) / 8.308 
Picture 
recognition 
z = (asin (sqrt (RS / 30.5)) - (1.460 - 0.0042 × A + 0.0055 × E + 0.056 × G + 0.0006 × (A - Amean) x 
G)) / 0.115 
Spatial span 
z = (RS1.4 - (31.811 - 0.245 × A + 0.141 × E - 0.964 × G + 0.185 × (A - Amean) × G + 0.050 × (E - 
Emean)2)) / 5.031 
Digit span* z = (RS - (11.736 - 0.053 × A + 0.087 × E - 0.811 × G - 0.0079 × (A - Amean)2)) / 1.923 
TMT-A 
z = (RS0.75 - (18.48 - 0.0912 × A - 0.136 × E + 0.064 × G + 0.241 × (E - Emean) × G + 0.026 × (E - 
Emean )2)) / 1.998 
TMT-B z = (RS1.5 - (153.17 - 1.488 × A + 1.2636 × E)) / 21.653 
 
The basic formula for the calculation of standard scores is z = (transformed score - expected score) 
/ residual standard error. 
*No transformation was necessary to receive normal distribution for the digit span score. 
A = age; E = education; G = gender; RS = raw score; TMT = Trail Maki g Test. 
  
 76 
were applied. This eliminates potential confounders (presence of mild cognitive 
impairment, dementia, or depression) and leads to almost ideal normative data. 
Hence, clinicians may better interpret test results of patients affected by conditions 
associated with poor cognitive performance. Subjects with medical comorbidities 
commonly found in the elderly (Table 1) were intentionally not excluded from the 
study for a better representation of the geriatric population. 
We used a regression-based analysis to calculate normative data for each subtest 
of the assessment application. This approach considers specific demographical 
data that are critical for an appropriate estimation of the individual performance and 
does not rely on categories (e.g., age groups) which are somewhat arbitrary. This 
increases the diagnostic accuracy in subjects at the extremes of such groups. 
The composition of different cognitive tests in CogCheck may result in a more 
adequate assessment, as cognitive impairment and dementia may affect different 
domains of cognition. Assessing a smaller number of domains for the benefit of 
time may not capture the complete picture of cognitive impairment. The CogCheck 
application, in turn, has a multidimensional character. 
Limitations of our study include the potential selection bias resulting in super-
optimal normative data. Participants included in this study were recruited from an 
existing registry of nonsurgical volunteers. These individuals might have a higher 
intellect or display a greater motivation to perform well in cognitive testing than the 
average population. This bears the risk of overestimating cognitive impairment if 
interpretation of individual performance is missed. Therefore, our normative data 
must be considered as a guideline, and test results of patients from very different 
cultural backgrounds or individuals with very low education require cautious 
interpretation. It was decisive to include only individuals with established cognitive 
health, since their scores serve as starting points for the interpretation of scores 
from actual patients. This healthy normative sample will not be representative of 
older adults requiring surgery in all aspects, and expected differences will have to 
be explained on clinical grounds. Finally, since CogCheck was envisioned as a one-
time screening test, we did not study the possibility of repeated/longitudinal 
assessment and tracing of a perioperative cognitive trajectory in individual patients, 
as well as the test-retest reliability. 
Normative data are essential for any assessment tool, even when a traditional 
examiner-administered test is programmed for use on a computer, as it becomes a 
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new and different test (Bauer et al., 2012). The general question arises whether 
computerized assessment is appropriate for use in the elderly. One could assume 
that elderly people who are used to electronic devices may achieve better test 
results than those who are not, or do not feel comfortable using computers. 
However, previous findings suggest that the level of computer experience among 
older adults is not associated with the performance in a computerized test (Fazeli 
et al., 2013). Moreover, a recent literature review showed that people with dementia 
are able to independently use touchscreen technology (Joddrell & Astell, 2016). A 
disadvantage of computerized testing is the absence of an opportunity to motivate 
the patient as an examiner would be able to do. Nevertheless, self-administration 
is more resource-efficient and eliminates potential rater-related bias. 
Traditional neuropsychological assessment batteries such as the CERAD-NAB are 
strongly based on verbal language. In contrast, the cognitive subtests in CogCheck 
are entirely language-free. A number of automated tools to assess cognitive 
functions also require the presence of a bedside examiner, include tests with a 
computer-generated voice (which can be difficult for patients with impaired 
hearing), or need handling of hardware (stylus, computer mouse, or keyboard). 
Some high-quality computerized applications (Zygouris & Tsolaki, 2015) like 
COGNIGRAM (CogState Ltd), CANTAB Mobile (Cambridge Cognition Ltd; Robbins 
et al. [1994]), or the NIH Toolbox (Health Measures) require the purchase of a 
license. However, considering recent health care resource cuts, paid single 
assessments may hinder the broad use of these tools in clinical practice (Weir et 
al., 2014; Zygouris & Tsolaki, 2015). We plan to make the CogCheck application 
available for free to any interested clinician and researcher. While some 
assessment tools take longer, the average time of 21.7 minutes needed to complete 
CogCheck seems reasonable. In addition, our tool screens for preoperative risk 
factors beyond pre-existing cognitive impairment (e.g., polymedication). 
The current European and American guidelines on adverse postoperative cognitive 
outcomes recommend preoperative screening for risk factors including mental 
status for any patient without known history of cognitive impairment (Aldecoa et al., 
2017; Mohanty et al., 2016). Preoperative screening may not only help to identify 
vulnerable patients but also guide preventive strategies. A standardized cognitive 
evaluation before surgery may offer important baseline information in patients 
experiencing postoperative cognitive decline. Still, the implementation of routine 
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screening for cognitive impairment in surgical patients may be challenging in daily 
practice (van Meenen, van Meenen, de Rooij, & ter Riet, 2014). 
Since this study first provides normative data for an elderly nonsurgical population, 
CogCheck application data may not yet be used in a risk prediction model of 
adverse postoperative cognitive outcomes in surgical patients. Validation of the 
CogCheck application with postoperative outcome data is necessary before it may 
fully enter clinical routine. We plan to investigate the association of CogCheck 
performance and POD incidence in a follow-up study of patients undergoing cardiac 
surgery. Succeeding validation of the tool, CogCheck opens a wide field of 
research. Identifying vulnerable patient populations may simplify the study of 
targeted preventive measures to reduce the incidence of adverse postoperative 
cognitive outcomes (e.g., nonpharmacological multicomponent strategies [Inouye 
et al., 1999], cognitive or physical prehabilitation, prophylactic medication, and 
perioperative anesthetic considerations). Automatic data integration with digital 
records (e.g., medical history, medication lists, laboratory values, type of surgery) 
is conceivable in the future. 
 
5.5 CONCLUSIONS 
This study in healthy nonsurgical volunteers provides normative data for the 
CogCheck cognitive assessment tool. The CogCheck application measures the 
individual cognitive performance adjusted for demographic influences. However, 
clinical implementation of CogCheck  to identify surgical patients with a high risk for 
adverse postoperative cognitive outcomes will only be possible after validation of 
the tool. In future research directed at the targeted prevention of adverse 
postoperative cognitive outcomes, this simple self-administered assessment tool 
may provide important information regarding the preoperative cognitive status. 
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Supplementary material 
Supplemental digital content 1. Screenshots of CogCheck.
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Instructions Part 2 
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Visual recognition: Video 
 
 
Visual recognition: Presentation 
 
 
Visual recognition: Selection 
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Picture learning and recognition: 
Memorizing images 
 
 
Digit span: 
Memorizing numerical series 
 
Digit span: 
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Spatial span 
 
 
Reaction time and attention 
 
 
Trail Making Test A 
 
 
Trail Making Test B 
 
 
Picture learning and recognition: 
Recalling images 
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Supplemental digital content 2. Description of CogCheck subtests.  
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Supplemental digital content 3. Influence of demographic characteristics on 
CogCheck subtests. 
 
Visual recognition 
 
The best predictive model for the visual recognition score included age (β = -
0.398, SE = 0.095, P < 0.001) and education (β = 0.479, SE = 0.171, P = 0.006), 
which explained a significant amount of variance of the visual recognition score, F 
= 12.71, P < 0.001, R2 = 0.083 (adjusted R2 = 0.077). In this model, older age, 
and lower education were associated with a lower visual recognition score.
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Picture recognition 
The best predictive model for the picture recognition score included age (β = -
0.004, SE = 0.001, P = 0.004), education (β = 0.005, SE = 0.002, P = 0.026), 
gender (β = 0.056, SE = 0.014, P < 0.001), and a quadratic formula for age (β = 
0.001, SE = 0.0002, P = 0.003), which explained a significant amount of variance 
of the picture recognition score, F = 7.56, P < 0.001, R2 = 0.098 (adjusted R2 = 
0.085). In this model, lower education, and male gender were associated with a 
lower picture recognition score. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Female Male 
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Spatial span 
The best predictive model for the spatial span score included age (β = -0.245, SE 
= 0.083, P = 0.004), education (β = 0.141, SE = 0.121, P = 0.25), gender (β = -
0.964, SE = 0.628, P = 0.13), the interaction of age and gender (β = 0.185, SE = 
0.116, P = 0.11), and a quadratic formula for education (β = 0.050, SE = 0.030, P 
= 0.10), which explained a significant amount of variance of the spatial span 
score, F = 4.02, P = 0.002, R2 = 0.068 (adjusted R2 = 0.051). In this model, older 
age, and female gender were associated with a lower spatial span score. 
Female Male 
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Digit span 
 
 
The best predictive model for the digit span score included age (β = -0.053, SE = 
0.024, P = 0.030), education (β = 0.087, SE = 0.041, P = 0.036), gender (β = -
0.811, SE = 0.239, P < 0.001), and a quadratic formula for age (β = -0.008, SE = 
0.003, P = 0.020), which explained a significant amount of variance of the digit 
span score, F = 9.13, P < 0.001, R2 = 0.117 (adjusted R2 = 0.104). In this model, 
lower education, and female gender were associated with a lower digit span 
score. 
 
Reaction time and attention 
The initial assessment test included a reaction time and attention task. 
Participants were asked to tap on the screen as fast as possible if a star (n = 15) 
appeared in random order among other geometric forms (n = 15). 
We found a ceiling effect for this task, and it was declared to be too easy (80% 
reached the maximum score of hits and 83% made no mistake). Moreover, the 
reaction time measurements were hampered by a programming error. As this 
precluded any standardization procedure, the reaction time and attention task 
was discarded from the assessment application.  
Male Female 
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Trail Making Test A 
In Trail Making Test A (TMT-A), the ratio of correct line connections per minute 
was calculated to measure the accuracy of performance. The best predictive 
model for the TMT-A score included age (β = -0.091, SE = 0.023, P < 0.001), 
education (β = -0.136, SE = 0.079, P = 0.086), gender (β = 0.064, SE = 0.250, P 
= 0.80), the interaction of education and gender (β = 0.241, SE = 0.098, P = 
0.015), and a quadratic formula for education (β = 0.026, SE = 0.014, P = 0.068), 
which explained a significant amount of variance of the TMT-A score, F = 4.3, P < 
0.001, R2 = 0.073 (adjusted R2 = 0.056). In this model, older age was associated 
with a lower TMT-A score.  
Female Male 
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Trail Making Test B 
 
In Trail Making Test B (TMT-B), the ratio of correct line connections per minute 
was calculated to measure the accuracy of performance. The best predictive 
model for the TMT-B score included age (β = -1.488, SE = 0.249, P < 0.001) and 
education (β = 1.264, SE = 0.451, P = 0.005), which explained a significant 
amount of variance of the TMT-B score, F = 21.9, P < 0.001, R2 = 0.138 (adjusted 
R2 = 0.131). In this model, older age and lower education were associated with a 
lower TMT-B score. 
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6. General discussion 
In the presented studies, we have investigated the performance of cognitively 
healthy individuals in the German-version of a well-known screening tool for MCI 
(MoCA, study I) and in a newly developed self-administered computerized cognitive 
assessment (CogCheck, study III). Further, we have provided insight on the 
cognitive performance of patients with mild or major NCD in the MoCA, and we 
have introduced a new way to evaluate cognitive performance using two separate 
cut-offs (study II). Finally, we have discussed important heterogeneities between 
international normative studies which may inform future endeavors to create 
methodological guidelines in neuropsychology.   
 
6.1 Diagnostic accuracy and two separate cut-offs 
We have found demographic effects on cognitive performance in cognitively 
healthy individuals in the MoCA (study I), as well as in the CogCheck (study III). 
Consequently, we provided formulas to convert raw scores to demographically 
adjusted z-scores. Cognitively healthy individuals who are older and/or have lower 
educational attainment typically have lower cognitive performance and therefore 
are prone to false-positive test results. In study II, we tested this hypothesis and 
further assessed the diagnostic accuracy of the MoCA in consecutively referred 
Memory Clinic patients to distinguish patients with mild or major NCD from cognitive 
normal findings. As hypothesized, there were less false-positive test results when 
the MoCA z-score was applied to correct for demographic effects. However, using 
the MoCA z-score lead to decreased sensitivity to detect patients with mild or major 
NCD, which may be explained with age and education being important risk factors 
for dementia (Strauss et al., 2006). A follow-up study on the diagnostic accuracy of 
the CogCheck is currently in planning. 
While the diagnostic accuracy of the MoCA was very high to distinguish patients 
with mild or major NCD from cognitive normal findings, the classification of mild 
NCD only versus cognitively healthy individuals was more challenging. Indeed, 
there was always an unsatisfying trade-off between sensitivity and specificity. In 
the context of neurodegeneration and cognitive impairment, both—false negative 
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and false-positive results—have undesirable implications for the patient as well as 
for the healthcare system, and there is no valid reason to favor one over the other. 
Therefore, we have proposed a new way two evaluate cognitive performance on 
the MoCA by introducing two separate cut-offs in combination with a gray area. 
Specificity increases with lower scores, since healthy individuals typically have 
higher scores compared to patients. Inversely, higher scores are related to greater 
sensitivity, since patients typically have low scores. This is illustrated for the MoCA 
in Fig. 1. Instead of using one cut-off, which is always a trade-off between sensitivity 
and sensitivity, two separate cut-offs may be applied. A lower cut-off with high 
specificity and a higher cut-off with high sensitivity. Test results between these cut-
off scores are represented by a gray area and require further examination and/or 
follow-up testing. 
 
Fig. 1. Score distribution in patients with mild NCD and normal controls. 
 
In Fig. 1, the score distribution of patients with mild NCD vs. normal controls is 
illustrated. The overlap between the score distributions corresponds to the 
discriminative accuracy (expressed in the area under the curve [AUC]). A test with 
smaller overlap has higher discriminative power than a test with greater overlap. 
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Lower MoCA scores are typically associated with more cognitive impairment. This 
information is lost, when a continuous variable like the MoCA is binarized. 
Considering the difficulties, the field is facing in identifying subtle cognitive decline, 
it is important to identify potential sources of information. Applying two separate 
cut-offs may be one way to make use of additional information provided by the 
MoCA. Of course, these findings are preliminary. Follow-up studies are required to 
test this method in other settings and on tools other than the MoCA. Another way 
to profit from continuous information of the MoCA may be the analysis on a sub-
item level. Big data approaches and the use of machine learning algorithms have 
received increasing attention in clinical diagnostics (Sajda, 2006; Weakley, 
Williams, Schmitter-Edgecombe, & Cook, 2015). It is imaginable, that MoCA error-
patterns are specific for patients with different pathologies and that these patterns 
might be decoded using multivariate approaches. Additionally, feature selection 
may reveal which sub-items are especially informative for the classification of 
healthy individuals versus patients. If less informative items could be removed from 
the MoCA, its administration time could be shortened. Computerized cognitive 
assessments may facilitate future data collection and data-driven insights to this 
aim. 
 
6.2 Computerized cognitive assessment 
In study III, we have investigated a novel computerized cognitive assessment tool 
(CogCheck) in cognitively healthy individuals. Compared to paper-pencil tests, 
computerized test batteries have many advantages. In neuropsychology, one 
strategy is the evaluation of qualitative aspects of cognitive assessment. This 
strategy, known as the Boston Process Approach, is interested in how a patient 
gets to a result, in addition to evaluating the correctness of the answer (Casaletto 
& Heaton, 2017; Libon, Swenson, Ashendorf, Bauer, & Bowers, 2013) . With 
computerized assessments, such qualitative measures can easily be captured as 
a complement to a total score. For instance, reaction times, number and types of 
errors or self-corrections, and ways of proceeding can be assessed and evaluated. 
Moreover, the recognition of somatic symptoms, such as tremor, may also be 
included in a computerized tool to supplement cognitive measures. Digital 
measures of tremor relate very well to common clinical rating scales and even 
detected subtle abnormalities that are not captured in traditional clinical 
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assessments (Lipsmeier et al., 2018). Likewise, qualitative measures of cognition 
may provide valuable information in individuals who score within the normal range 
in standard cognitive assessments. Computerized assessments further yield the 
advantage of eliminating examiner-related bias, since the test items are always 
presented the exact same way. Moreover, assessments may be automatically 
adjusted in difficulty based on individual performance (Bauer et al., 2012). A 
neuropsychological assessment in the context of dementia diagnostics is usually 
performed just once or repeated only a few months later. Therefore, the gained 
insights are of cross-sectional nature and they may be biased if, for instance, a 
patient was very nervous at the time of testing. Moreover, the decline from a 
previous functional level may not be captured if an individual has a very high level 
of functioning. Computerized assessments may be administred repeatedly over a 
longer time-frame. This way, bias may be reduced by averaging the results and a 
possible decline becomes apparent.  
Computerized cognitive assessments may additionally increase the efficiency of a 
cognitive evaluation. Indeed, results are available immediately after examination, 
and automatic scoring is less prone to errors. Fewer materials and less trained 
personnel are required, thereby reducing costs. It is imaginable, that patients may 
complete computerized assessments at home, which enhances the accessibility for 
people who have difficulties to travel to a clinician (Casaletto & Heaton, 2017). In 
current neuropsychological assessments, a standardized set of cognitive tests is 
typically combined with a hypothesis-driven approach, where additional tests are 
administered based on a specific referral question or based on a suspicion of 
impairment in a particular cognitive domain. Following this approach, a 
computerized assessment could serve as a first step evaluation in all patients, to 
gain a global impression of cognitive performance. Individually selected, specific 
tests may then be administered only in those patients, where more information is 
required. Such a multi-step approach on the level of specialized cognitive 
assessment may enhance efficiency. 
While computerized cognitive assessments yield many advantages, there are 
challenges that need to be considered as well. It must be assured, that patients 
perform the test alone and without any additional help. Moreover, patients will 
typically be faced with their deficits during a cognitive assessment, which may 
affect the motivation to continue the evaluation. Neuropsychologists are trained to 
help motivate a patient in these situations. It should be evaluated, whether and to 
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what extent this lack of a motivating healthcare professional affects the use of self-
administered computerized cognitive assessments. The absence of a trained 
professional may also have a negative impact on diagnostic conclusions, when 
individual characteristics that may impact cognitive performance (e.g., lack of 
motivation, sensorimotor impairment, very low educational attainment) are not 
considered for test interpretation (American Academy of Clinical Neuropsychology, 
2007; Bauer et al., 2012). Further, important ethical and data safety considerations 
should be considered, especially if a computerized tool is connected to the Internet. 
Finally, the psychometric properties of any cognitive assessment tool need to be 
evaluated (Casaletto & Heaton, 2017) and normative values are required. The 
reliability and validity of CogCheck will therefore have to be investigated in follow-
up studies before its application in a clinical setting. Further, other important 
questions need to be addressed for the successful implementation of computerized 
cognitive assessment tools in clinical neuropsychology. To what extent are the 
psychometric properties altered in a computerized tool? How do technical changes, 
on a current test version, alter the psychometric properties of the updated version? 
Are normative values, that have been developed in one setting, transferable to 
other settings? How well do normative values from one culture translate to another? 
 
6.3 Definition of cognitive health and selection of patient groups 
Whether normative values that have been developed in one country or in a specific 
setting are representable for other countries/settings is a central question, that the 
field of neuropsychology needs to address (Casaletto & Heaton, 2017). Indeed, it 
is expensive to conduct normative studies and it is not possible to create new 
normative values in every language and every setting. Additionally, norms that have 
been created in older generations may not translate to newer generations and may 
need to be renewed. As outlined in the previous chapter, computerized cognitive 
assessments are becoming more popular. However, technical developments 
underlie rapid changes and new technical advances are usually quickly outdated 
and replaced by newer technologies. This rapidly changing environment is a main 
challenge that needs to be addressed in neuropsychology.  It is simply impossible 
to keep up with the technical advances if normative values should be gathered for 
every new version of a tool.  
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Therefore, the field would benefit from the knowledge whether and to what extent 
norms are generalizable across different cultures and settings. However, 
answering this question requires a clear consensus and guidelines on (a) the 
requirements of a normative sample and (b) the methodology that is used to create 
norms. Only then, the potential differences in cognitive performance between 
cultures/settings may truly be attributable to these factors. Otherwise, an 
alternative explanation for the observed differences may be the inhomogeneity in 
subject selection and methodology. 
In a side project (Thomann, Goettel, Hessler, et al., 2018), we have compared 
MoCA scores from culturally similar study centers (i.e. the Basel normative sample 
[Thomann, Goettel, Monsch, et al., 2018] vs. a normative sample from Munich, 
Germany/Vienna, Austria) and found significantly different mean MoCA scores (p 
< .001) between the two study centers. In a regression-model, lower MoCA scores 
were associated with higher age (p = .005), lower education (p = .003), male sex 
(p = .018), and study center (Munich/Vienna; p = .003). There is no reason to 
assume, that cognitive performance in Swiss participants would differ from the 
performance in the culturally- and language-related German and Austrian 
participants. Moreover, there were no interactions between study center and 
demographic characteristics that could explain the difference in mean MoCA 
scores. Therefore, we compared the samples regarding their inclusion/exclusion 
criteria and found important differences, on how cognitive health was defined 
(CERAD total score and MMSE cut-off in Basel vs. subjective memory complaints 
in Munich/Vienna). These dissimilarities in exclusion criteria may explain the 
observed differences in mean MoCA total scores.  
Likewise, we have found differences in mean MoCA total scores between 
international MoCA normative studies (study I). Again, there were important 
dissimilarities with respect to the methodology and the sample characteristics 
between these studies. Notably, the definition of cognitive health was largely 
inconsistent. There seems to be no clear consensus regarding the selection of 
cognitively healthy individuals for a normative study, and opinions diverge in 
whether a population-based approach or a sample with indisputable cognitively 
healthy individuals to create robust norms should be favored (Casaletto & Heaton, 
2017; Martin et al., 2017; Strauss et al., 2006). Some argue, that cognitively healthy 
individuals constitute a sample of “superhealthy” individuals who are not 
representative for the general population. In study II, we therefore compared our 
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healthy normative sample to cognitive normal findings from clinical routine and we 
have found no difference in the MoCA performance between these two groups. 
This suggests that a purposely-recruited cognitively healthy sample is 
representable for cognitive normal findings from clinical routine. However, this 
result should be completed by longitudinal data in future investigations. 
The field of AD research in general could profit from (a) a clear definition of 
cognitive health and (b) revised criteria for cognitive impairment. When actuarial 
neuropsychological criteria are used to define MCI, more patients and healthy 
individuals are correctly classified (Bondi et al., 2014; Edmonds et al., 2018; 
Edmonds et al., 2016). This is essential for clinical care, to ensure that only patients 
receive further examinations and treatments. Moreover, such criteria are important 
in clinical research, since including the correct participants in a study (i.e., truly 
patients/truly healthy individuals) is fundamental. Indeed, the erroneous inclusion 
of patients as healthy participants in studies on diagnostic tests lowers the mean 
performance of the group, which in term leads to lower cut-off scores and may 
ultimately decrease sensitivity. Likewise, including healthy individuals as patients 
may severely bias study results and even mask treatment effects (Edmonds et al., 
2018). Moreover, wrong conclusions about the pathogenesis and the prediction of 
the disease course may be drawn.  
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7. Outlook 
The changes that arise from the demographical development, combined with the 
digitalization, yields challenges, as well as opportunities for our society and the 
healthcare system. Neuropsychology has important contributions to offer in facing 
these challenges and by modernizing the way we assess cognition. 
The rapidly growing segment of older people requires fast and accurate diagnostic 
methods to identify patients with cognitive disorders. The field of neuropsychology 
needs to incorporate new insights of brain-behavior relationships into the current 
clinical practice to address this. Further, new opportunities that arise form technical 
advances should be seized to keep the neuropsychological instruments up to date. 
Computerized cognitive assessments yield the advantage of highly time- and 
resource-efficient examinations. They may additionally facilitate the development 
of normative values, since computerized assessments may be made available as 
a mobile application in large-scale studies to a broad range of individuals without 
the presence of a trained examiner (e.g., GameChanger study [Alzheimer’s 
Society, 2019]). Such mobile applications have been used in other disease areas 
for daily symptom assessment with active and passive measures (Lipsmeier et al., 
2018). Therefore, the digitalization offers huge opportunities to gather information 
from many different sources that may open new insights on healthy or pathological 
processes and which might be translated into so-called digital biomarkers. 
Hypothesis-free cluster analyses may then be applied to investigate, whether there 
are specific groups of patients with individual characteristics, which need to be 
considered to enhance diagnostic accuracy.  
The approach of precision medicine increasingly gains popularity in the context of  
treatment and prevention of diseases. The consideration of individual differences 
may also be meaningful for the diagnostic process. In future studies, it may 
therefore be interesting to investigate whether other characteristics than education, 
age, or sex should be considered when cognitive performance is evaluated. For 
instance, cognitive performance is often discussed in the context of cognitive 
reserve (Stern, 2009), which postulates a protection against the harmful effects of 
neurodegeneration. Cognitive reserve may be modulated over the life course 
through cognitive activity or a complex occupation. Current research aims at finding 
a reliable marker for cognitive reserve, which may be incorporated in cognitive 
assessments as a co-variate. Moreover, some populations with above-normal 
  
 99 
behavioral phenotypes show altered brain connections (Brauchli, Leipold, & 
Jancke, 2019) and enhanced cognitive abilities (Mealor, Simner, & Ward, 2019) 
compared to control groups, which in term could lead to performance differences 
in cognitive assessments. In conclusion, the field of neuropsychology has some 
interesting questions left to answer, which may help increase our understanding of 
brain-behavior-relationships and of possible alterations of these interactions by 
normal ageing. Such knowledge is central to further gain new insights into 
pathological ageing mechanisms. Ultimately, we need to find ways to disentangle 
the overlapping distributions between patients and healthy individuals. This may be 
achieved by the incorporation of new information, the use of new technologies, and 
the consideration of individual differences. One promising approach might be the 
combination of multimodal information with decision tree algorithms. There may be 
ways to screen for subtle symptoms with very few effort or even with passive 
monitoring through digital wearables or smartphones. Complemented with known 
characteristics of an individual, learning algorithms may automatically analyze 
which further diagnostic steps are indicated. However, the approach of precision 
medicine may also require clear methodological guidelines and internationally 
harmonized definitions for cognitive health and cognitive impairment. Otherwise, 
variability that arises from methodological dissimilarities may be misinterpreted as 
individual differences, or individual differences may be masked.    
In conclusion, efficiency and diagnostic accuracy can be enhanced by applying 
automated, self-administrated, and simple diagnostic tools for the general 
population in combination with more specific further examinations that are tailored 
to the needs and characteristics of a specific individual. 
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